☒Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

☐Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~November 4, 2021,~~August 1, 2022, the registrant had ~~78,652,200~~79,037,931 shares of common stock, par value $0.01 per share, outstanding.

	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	September 30,						September 30,						June 30,						June 30,
	2021			2020			2021			2020			2022			2021			2022			2021
Revenues
Sales	$	231		$	195		$	674		$	568		$	266		$	234		$	500		$	443
Services		56			57			169			164			55			57			111			113
Total revenues		287			252			843			732			321			291			611			556
Cost of revenues
Sales		206			183			595			533			234			204			454			389
Services		38			38			117			111			36			39			73			79
Total cost of revenues		244			221			712			644			270			243			527			468
Gross profit		43			31			131			88			51			48			84			88
Selling, general and administrative expenses		43			56			131			138			41			42			84			88
Research and development costs		8			8			24			25			9			8			18			16
Restructuring costs and other		—			1			1			9			—			—			—			1
Other operating expense (income), net		1			(1	)		(6	)		(11	)
Loss from operations before interest expense, pension income excluding service cost component, loss on early extinguishment of debt, other (income) charges, net and income taxes		(9	)		(33	)		(19	)		(73	)
Other operating income, net														—			(6	)		—			(7	)
Earnings (loss) from operations before interest expense, pension income excluding service cost component, other (income) charges, net and income taxes														1			4			(18	)		(10	)
Interest expense		9			3			23			11			10			10			19			14
Pension income excluding service cost component		(25	)		(26	)		(76	)		(79	)		(27	)		(26	)		(57	)		(51	)
Loss on early extinguishment of debt		—			2			—			2
Other (income) charges, net		(2	)		432			(1	)		387			(1	)		1			2			1
Earnings (loss) from operations before income taxes		9			(444	)		35			(394	)
Provision for income taxes		1			1			5			167
Net income (loss)	$	8		$	(445	)	$	30		$	(561	)
Earnings from operations before income taxes														19			19			18			26
(Benefit) provision for income taxes														(1	)		3			1			4
Net income													$	20		$	16		$	17		$	22

Basic net income (loss) per share attributable to Eastman Kodak Company common shareholders	$	0.06		$	(6.94	)	$	0.40		$	(11.34	)
Diluted net income (loss) per share attributable to Eastman Kodak Company common shareholders	$	0.06		$	(6.94	)	$	0.39		$	(11.34	)
Basic net income per share attributable to Eastman Kodak Company common shareholders													$	0.20		$	0.17		$	0.13		$	0.33
Diluted net income per share attributable to Eastman Kodak Company common shareholders													$	0.19		$	0.16		$	0.12		$	0.32

Number of common shares used in basic and diluted net income (loss) per share
Number of common shares used in basic and diluted net income per share
Basic		78.6			64.8			78.3			50.8			78.9			78.5			78.8			78.2
Diluted		80.6			64.8			80.5			50.8			90.2			100.6			80.4			93.9

The accompanying notes are an integral part of these consolidated financial statements.

	September 30,			December 31,			June 30,			December 31,
(in millions)	2021			2020			2022			2021
ASSETS
Cash and cash equivalents	$	380		$	196		$	289		$	362
Trade receivables, net of allowances of $8 and $10, respectively		167			177
Trade receivables, net of allowances of $7 and $7, respectively								191			175
Inventories, net		240			206			262			219
Other current assets		47			46			44			49
Current assets held for sale		2			2			2			2
Total current assets		836			627			788			807
Property, plant and equipment, net of accumulated depreciation of $440 and $430, respectively		140			152
Property, plant and equipment, net of accumulated depreciation of $443 and $441, respectively								145			140
Goodwill		12			12			12			12
Intangible assets, net		35			39			32			34
Operating lease right-of-use assets		46			48			43			47
Restricted cash		64			53			57			54
Pension and other postretirement assets								1,181			1,022
Other long-term assets		402			317			51			55
TOTAL ASSETS	$	1,535		$	1,248		$	2,309		$	2,171

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY
Accounts payable, trade	$	151		$	118		$	168		$	153
Short-term borrowings and current portion of long-term debt		2			2			1			1
Current portion of operating leases		18			12			12			13
Other current liabilities		141			164			137			142
Total current liabilities		312			296			318			309
Long-term debt, net of current portion		250			17			308			253
Pension and other postretirement liabilities		384			406			358			382
Operating leases, net of current portion		40			49			39			45
Other long-term liabilities		210			212			186			205
Total liabilities		1,196			980			1,209			1,194

Commitments and Contingencies (Note 8)
Commitments and Contingencies (Note 7)

Redeemable, convertible preferred stock, no par value, $100 per share liquidation preference	195			191			199			196

Equity
Common stock, $0.01 par value		—			—			—			—
Additional paid in capital		1,166			1,152			1,164			1,166
Treasury stock, at cost		(10	)		(9	)		(10	)		(10	)
Accumulated deficit		(590	)		(620	)		(579	)		(596	)
Accumulated other comprehensive loss		(422	)		(446	)
Accumulated other comprehensive income								326			221
Total shareholders’ equity		144			77			901			781
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY	$	1,535		$	1,248		$	2,309		$	2,171

The accompanying notes are an integral part of these consolidated financial statements.

	Nine Months Ended						Six Months Ended
	September 30,						June 30,
(in millions)	2021			2020			2022			2021
Cash flows from operating activities:
Net income (loss)	$	30		$	(561	)
Net income							$	17		$	22
Adjustments to reconcile to net cash used in operating activities:
Depreciation and amortization		23			29			14			16
Pension income		(63	)		(65	)		(49	)		(42	)
Change in fair value of embedded derivatives in the Series A, Series B and Series C Preferred Stock and Convertible Notes		(3	)		382
Loss on early extinguishment of debt		—			2
Net loss (gain) on sales of assets		1			(9	)
Asset impairments		—			3
Change in fair value of the Preferred Stock and Convertible Notes embedded derivatives								(1	)		—
Non-cash changes in workers' compensation reserves								(8	)		(3	)
Stock based compensation		6			18			3			4
Non-cash changes in workers' compensation reserves		(4	)		9
(Benefit) provision for deferred income taxes		(1	)		160
Decrease in trade receivables		6			53
Increase in deferred taxes								(2	)		—
(Increase) decrease in trade receivables								(26	)		1
Increase in inventories		(38	)		(19	)		(54	)		(30	)
Increase (decrease) in trade payables		33			(33	)
Increase in trade payables								17			27
Decrease in liabilities excluding borrowings and trade payables		(26	)		(24	)		(17	)		(20	)
Other items, net		3			7			3			4
Total adjustments		(63	)		513			(120	)		(43	)
Net cash used in operating activities		(33	)		(48	)		(103	)		(21	)
Cash flows from investing activities:
Additions to properties		(10	)		(13	)		(9	)		(5	)
Net proceeds from sales of assets		1			2
Net proceeds from return on equity investment		—			2
Net cash used in investing activities		(9	)		(9	)		(9	)		(5	)
Cash flows from financing activities:
Net proceeds from Term Loan Credit Agreement		215			—			49			215
Net proceeds from Convertible Notes		25			—			—			25
Net proceeds from Series C Preferred Stock		99			—			—			99
Proceeds from sale of common stock		10			—			—			10
Repurchase of Series A Preferred Stock		(100	)		—			—			(100	)
Debt issuance costs		(2	)		—			—			(2	)
Proceeds from stock option exercises		—			29
Preferred stock cash dividend payments		(6	)		(19	)		(2	)		(5	)
Treasury stock purchases		(1	)		—			—			(1	)
Net cash provided by financing activities		240			10			47			241
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(3	)		(2	)		(5	)		(2	)
Net increase (decrease) in cash, cash equivalents and restricted cash		195			(49	)
Net (decrease) increase in cash, cash equivalents and restricted cash								(70	)		213
Cash, cash equivalents and restricted cash, beginning of period		256			290			423			256
Cash, cash equivalents and restricted cash, end of period	$	451		$	241		$	353		$	469

The accompanying notes are an integral part of these consolidated financial statements.

Nine-Month Period Ending September 30, 2021

Eastman Kodak Company Common Shareholders

Common
Stock

Additional
Paid in
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive Loss

Treasury
Stock

Total

Redeemable
Convertible
Preferred
Stock

Equity (deficit) as of December 31, 2020

$
—

$
1,152

$
(620
)

$
(446
)

$
(9
)

$
77

$
191

Net income

—

—

6

—

—

6

—

Other comprehensive income (loss)
   (net of tax):

Currency translation adjustments

—

—

—

(1
)

—

(1
)

—

Pension and other postretirement
   liability adjustments

—

—

—

6

—

6

—

Repurchase of Series A preferred stock

—

—

—

—

—

—

(100
)
Exchange of Series A preferred stock

—

92

—

—

—

92

(92
)
Expiration of Series A preferred stock
   embedded derivative

—

11

—

—

—

11

—

Issuance of convertible, redeemable
   Series B preferred stock, net

(95
)

(95
)

93

Issuance of common stock

—

10

—

—

—

10

—

Issuance of convertible, redeemable
   Series C preferred stock, net

—

—

—

—

—

—

97

Preferred stock cash dividends

—

(1
)

—

—

—

(1
)

—

Preferred stock deemed dividends

—

(2
)

—

—

—

(2
)

2

Series C Preferred stock in-kind
   dividends

—

(1
)

—

—

—

(1
)

1

Purchase of treasury stock ⁽¹⁾

—

—

—

—

(1
)

(1
)

—

Stock-based compensation

—

3

—

—

—

3

—

Equity (deficit) as of March 31, 2021

$
—

$
1,169

$
(614
)

$
(441
)

$
(10
)

$
104

$
192

Net income

—

—

16

—

—

16

—

Other comprehensive income (loss)
   (net of tax):

Currency translation adjustments

—

—

—

4

—

4

—

Pension and other postretirement
   liability adjustments

—

—

—

8

—

8

—

Series B Preferred stock cash
   dividends

—

(2
)

—

—

—

(2
)

—

Series C Preferred stock in-kind
   dividends

—

(1
)

—

—

—

(1
)

1

Stock-based compensation

—

1

—

—

—

1

—

Equity (deficit) as of June 30, 2021

$
—

$
1,167

$
(598
)

$
(429
)

$
(10
)

$
130

$
193

Net income

—

—

8

—

—

8

—

Other comprehensive income (loss)
   (net of tax):

Pension and other postretirement
   liability adjustments

—

—

—

7

—

7

—

Series B Preferred stock cash
   dividends

—

(1
)

—

—

—

(1
)

—

Series C Preferred stock in-kind
   dividends

—

(1
)

—

—

—

(1
)

1

Preferred stock deemed dividends

—

(1
)

—

—

—

(1
)

1

Stock-based compensation

—

2

—

—

—

2

—

Equity (deficit) as of September 30, 2021

$
—

$
1,166

$
(590
)

$
(422
)

$
(10
)

$
144

$
195

	Six-Month Period Ending June 30, 2022
	Eastman Kodak Company Common Shareholders
	Common Stock		Additional Paid in Capital			Accumulated Deficit			Accumulated Other Comprehensive Income			Treasury Stock			Total			Redeemable Convertible Preferred Stock
Equity (deficit) as of December 31, 2021	$	—	$	1,166		$	(596	)	$	221		$	(10	)	$	781		$	196
Net loss		—		—			(3	)		—			—			(3	)		—
Other comprehensive income (net of tax):
Currency translation adjustments		—		—			—			5			—			5			—
Preferred stock cash dividends		—		(1	)		—			—			—			(1	)		—
Preferred stock in-kind dividends		—		(1	)		—			—			—			(1	)		1
Preferred stock deemed dividends		—		(1	)		—			—			—			(1	)		1
Stock-based compensation		—		2			—			—			—			2			—
Equity (deficit) as of March 31, 2022	$	—	$	1,165		$	(599	)	$	226		$	(10	)	$	782		$	198
Net income		—		—			20			—			—			20			—
Other comprehensive (loss) income (net of tax):
Currency translation adjustments		—		—			—			(10	)		—			(10	)		—
Pension and other postretirement liability adjustments		—		—			—			110			—			110			—
Preferred stock cash dividends		—		(1	)		—			—			—			(1	)		—
Preferred stock in-kind dividends		—		(1	)		—			—			—			(1	)		1
Stock-based compensation		—		1			—			—			—			1			—
Equity (deficit) as of June 30, 2022	$	—	$	1,164		$	(579	)	$	326		$	(10	)	$	901		$	199

Nine-Month Period Ending September 30, 2020

Eastman Kodak Company Common Shareholders

Common
Stock

Additional
Paid in
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive Loss

Treasury
Stock

Total

Redeemable
Convertible
Preferred
Stock

Equity (deficit) as of December 31, 2019

$
—

$
604

$
(79
)

$
(417
)

$
(9
)

$
99

$
182

Net loss

—

—

(111
)

—

—

(111
)

—

Other comprehensive income (loss)
   (net of tax):

Currency translation adjustments

—

—

—

(12
)

—

(12
)

—

Pension and other postretirement
   liability adjustments

—

—

—

3

—

3

—

Series A preferred stock cash dividends

—

(3
)

—

—

—

(3
)

—

Series A preferred stock deemed
   dividends

—

(2
)

—

—

—

(2
)

2

Stock-based compensation

—

1

—

—

—

1

—

Equity (deficit) as of March 31,
   2020

$
—

$
600

$
(190
)

$
(426
)

$
(9
)

$
(25
)

$
184

Net loss

—

—

(5
)

—

—

(5
)

—

Other comprehensive income (loss)
   (net of tax):

Currency translation adjustments

—

—

—

(4
)

—

(4
)

—

Pension and other postretirement
   liability adjustments

—

—

—

9

—

9

—

Series A preferred stock cash
   dividends

—

(3
)

—

—

—

(3
)

—

Series A preferred stock deemed
   dividends

—

(2
)

—

—

—

(2
)

2

Equity (deficit) as of June 30, 2020

$
—

$
595

$
(195
)

$
(421
)

$
(9
)

$
(30
)

$
186

Net loss

—

—

(445
)

—

—

(445
)

—

Other comprehensive income (loss)
   (net of tax):

Currency translation adjustments

—

—

—

(1
)

—

(1
)

—

Pension and other postretirement
   liability adjustments

—

—

—

3

—

3

—

Series A preferred stock cash
   dividends

—

(2
)

—

—

—

(2
)

—

Series A preferred stock deemed
   dividends

—

(3
)

—

—

—

(3
)

3

Conversion of Convertible Notes

—

520

—

—

—

520

—

Stock options exercised

—

29

—

—

—

29

—

Stock-based compensation

—

17

—

—

—

17

—

Equity (deficit) as of September 30, 2020

$
—

$
1,156

$
(640
)

$
(419
)

$
(9
)

$
88

$
189

	Six-Month Period Ending June 30, 2021
	Eastman Kodak Company Common Shareholders
	Common Stock		Additional Paid in Capital			Accumulated Deficit			Accumulated Other Comprehensive Loss			Treasury Stock			Total			Redeemable Convertible Preferred Stock
Equity (deficit) as of December 31, 2020	$	—	$	1,152		$	(620	)	$	(446	)	$	(9	)	$	77		$	191
Net income		—		—			6			—			—			6			—
Other comprehensive income (loss) (net of tax):
Currency translation adjustments		—		—			—			(1	)		—			(1	)		—
Pension and other postretirement liability adjustments		—		—			—			6			—			6			—
Repurchase of Series A preferred stock		—		—			—			—			—			—			(100	)
Exchange of Series A preferred stock		—		92			—			—			—			92			(92	)
Expiration of Series A preferred stock embedded derivative		—		11			—			—			—			11			—
Issuance of convertible, redeemable Series B preferred stock, net				(95	)											(95	)		93
Issuance of common stock		—		10			—			—			—			10			—
Issuance of convertible, redeemable Series C preferred stock, net		—		—			—			—			—			—			97
Preferred stock cash dividends		—		(1	)		—			—			—			(1	)		—
Preferred stock deemed dividends		—		(2	)		—			—			—			(2	)		2
Preferred stock in-kind dividends		—		(1	)		—			—			—			(1	)		1
Purchase of treasury stock ⁽¹⁾		—		—			—			—			(1	)		(1	)		—
Stock-based compensation		—		3			—			—			—			3			—
Equity (deficit) as of March 31, 2021	$	—	$	1,169		$	(614	)	$	(441	)	$	(10	)	$	104		$	192
Net income		—		—			16			—			—			16			—
Other comprehensive income (net of tax):
Currency translation adjustments		—		—			—			4			—			4			—
Pension and other postretirement liability adjustments		—		—			—			8			—			8			—
Preferred stock cash dividends		—		(2	)		—			—			—			(2	)		—
Preferred stock deemed dividends		—		(1	)		—			—			—			(1	)		1
Stock-based compensation				1												1
Equity (deficit) as of June 30, 2021	$	—	$	1,167		$	(598	)	$	(429	)	$	(10	)	$	130		$	193

The accompanying notes are an integral part of these consolidated financial statements.

The consolidated interim financial statements are unaudited, and certain information and footnote disclosures related thereto normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been omitted in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying unaudited consolidated interim financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results of operations, financial position and cash flows of Eastman Kodak Company ~~(“EKC” or the “Company”)~~ and all companies directly or indirectly controlled, either through majority ownership or otherwise ~~(collectively, “Kodak”~~(“Kodak” or the “Company”). The results of operations for the interim periods are not necessarily indicative of the results for the entire fiscal year. These consolidated interim statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 (the ~~“2020~~“2021 Form 10-K”).

~~Certain amounts for prior periods have been reclassified to conform to the current period classification in the disaggregated revenue information for the Advanced Materials and Chemicals segment.~~

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20)” and “Derivatives and Hedging—ContractsNo accounting pronouncements have been adopted in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”, which simplifies accounting for convertible instruments. More convertible debt instruments will be reported as a single liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted EPS calculation in certain circumstances. The ASU is ~~effective January 1, 2024 for Kodak.~~ Early adoption is permitted for all entities for fiscal years beginning after December 15, 2020. The ASU allows entities to use either a modified retrospective or full retrospective transition method. Kodak adopted this ASU on January 1, 2021 using the modified retrospective method, under which companies apply the guidance to all financial instruments that are outstanding as of the beginning of the year of adoption with the cumulative effect recognized as an adjustment to the opening balance of retained earnings. The adoption of this standard had no impact on Kodak’s financial statements.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which removes certain exceptions related to intra-period tax allocations and deferred tax accounting on outside basis differences in foreign subsidiaries and equity method investments. Additionally, it provides other simplifying measures for the accounting for income taxes. The new standard is effective for fiscal years beginning after December 15, 2020 (January 1, 2021 for Kodak). Kodak adopted this ASU prospectively on January 1, 2021 and it did not have any impact on Kodak’s consolidated financial statements. 2022.

In July 2021, the FASB issued ASU 2021-05, “Leases (Topic 842): Lessors—Certain Leases with Variable Lease Payments”. Under this ASU, lessors should classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if both of the following criteria are met: (1) the lease would have been classified as a sales-type lease or a direct financing lease in accordance with the classification criteria in Topic 842 and (2) the lessor would have otherwise recognized a day-one loss. The amendments are effective for fiscal years beginning after December 15, 2021 and interim periods within those fiscal years for all public business entities ~~(January 1, 2022 for Kodak).~~ Entities that have adopted Topic 842 before the issuance date of this update have the option to apply the amendments in this update either (1) retrospectively to leases that commenced or were modified on or after the adoption of ASU 2016-02, “Leases (Topic 842)” or (2) prospectively to leases that commence or are modified on or after the date that an entity first applies the amendments. Earlier application is permitted. ~~Kodak adopted this ASU prospectively on October 1, 2021. The adoption did not have an impact on Kodak’s consolidated financial statements.~~

In June 2016, the ~~FASB~~Financial Accounting Standards Board issued ~~ASU~~Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”. ASU 2016-13 (as amended by ASUs 2018-19, 2019-04, 2019-05, 2019-10, 2019-11, 2020-02, 2020-03 and ~~2020-03)~~2022-02) requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. In addition, the ASU requires credit losses relating to available-for-sale debt securities to be recorded through an allowance for credit losses. The amendments in this ASU broaden the information that an entity must consider in developing its expected credit loss estimate for assets measured either collectively or individually. The ASU is effective January 1, 2023, for Kodak, and interim periods within that fiscal year. Early adoption is permitted. Kodak is currently evaluating the impact of this ASU.

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Statement of Financial Position that sums to the total of such amounts shown in the Statement of Cash Flows:

Restricted cash reported in Other current assets on the Consolidated Statement of Financial Position primarily represents amounts that support hedging activities.

Restricted cash includes $45 million as of ~~September~~June 30, 2022 and December 31, 2021 representing the cash collateral required to be posted by the Company under the Letter of Credit Facility (“L/C Cash Collateral”). Restricted cash included $35 million as of December 31, 2020, supporting compliance with the Excess Availability threshold under the ABL Credit Agreement, as defined therein (Refer to Note 5, “Debt and Finance Leases” for information on the Restricted cash supporting the L/C Cash Collateral and the Excess Availability threshold). In addition, Restricted cash as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 includes an escrow of ~~$14~~$5 million and ~~$12~~$4 million, respectively, in China to secure various ongoing obligations under the agreements for a strategic relationship with Lucky HuaGuang Graphics Co. Ltd. Restricted cash also included $3$5 million and $4$3 million of security posted related to Brazilian legal contingencies as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively.

The Other component above consists of other miscellaneous long-term assets that, individually, were less than 5% of the total assets component within the Consolidated Statement of Financial Position as of the end of the preceding year, and therefore have been aggregated in accordance with Regulation S-X.

Debt and finance leases and related maturities and interest rates were as ~~follows at September 30, 2021 and December 31, 2020:~~follows:

(in millions)	Type	Maturity	Weighted-Average Effective Interest Rate	September 30, 2021		December 31, 2020		Type	Maturity	Weighted-Average Effective Interest Rate	June 30, 2022		December 31, 2022
Current portion:
	RED-Rochester, LLC	2033	11.46%	$	1	$	1
	Finance leases	Various	Various		1		1	RED-Rochester, LLC	2033	11.42%	$	1	$	1
					2		2					1		1
Non-current portion:
	Term note	2026	13.86%		222		—	Term loans	2026	13.81%		279		224
	Convertible debt	2026	17.27%		14		—	Convertible debt	2026	17.28%		16		15
	RED-Rochester, LLC	2033	11.46%		12		12	RED-Rochester, LLC	2033	11.42%		12		12
	Finance leases	Various	Various		1		3	Finance leases	Various	Various		—		1
	Other debt	Various	Various		1		2	Other debt	Various	Various		1		1
					250		17					308		253
				$	252	$	19				$	309	$	254

Annual maturities of debt and finance leases outstanding at ~~September~~June 30, ~~2021~~2022 were as follows:

On February 26, 2021, the Company entered into a Credit Agreement (the “Term Loan Credit Agreement”) with certain funds affiliated with Kennedy Lewis Investment Management LLC (“KLIM”) as lenders (the “Term Loan Lenders”) and Alter Domus (US) LLC, as administrative agent. Pursuant to the Term Loan Credit Agreement, the Term Loan Lenders provided the Company with (i) an initial term loan in the amount of $225 million, which was drawn in full on the same date, and (ii) a commitment to provide delayed draw term loans in an aggregate principal amount of up to $50 million on or before February 26, 2023 ~~(collectively,~~(the “Delayed Draw Term Loans” and collectively, with the initial term loan, the “Term Loans”). Net proceeds from the Term Loan Credit Agreement received on February 26, 2021 were $215 million ($225 million aggregate principal less $10 million in debt transaction costs). The delayed draw term loans were drawn down in full on June 15, 2022. Net proceeds received on June 15, 2022 were $49 million ($50 million of aggregate principal less $1 million in debt transaction costs). The maturity date of the Term Loans ~~have a~~ ~~five-year~~ ~~maturity~~is February 26, 2026 and the Term Loans are non-amortizing. Each of the capitalized and undefined terms has the meaning ascribed to such term in the Term Loan Credit Agreement.

The Term Loans bear interest at a rate of 8.5% per annum payable quarterly in cash and 4.0% per annum ~~Paid-In-Kind interest(“PIK”) or~~payable in cash on the maturity date or quarterly, at ~~the Company’s~~EKC’s option, for an aggregate interest rate of 12.5% per annum. The payment of interest only at the maturity date has the same effect as delivering additional debt instruments to the Term Loan Lenders and therefore is considered Paid-in-Kind (“PIK”). The Company elected the 4.0% per annum in PIK which is being added to the carrying value of the debt through the ~~term and interest~~term. Interest expense ~~will be~~is being recorded using the effective interest ~~method~~.method. The Term Loans are guaranteed by the Company and certain of its domestic subsidiaries (the “Subsidiary Guarantors”), and are secured by (i) a first priority lien on substantially all assets of the Company and the Subsidiary Guarantors (subject to certain exceptions) not constituting ABL Priority Collateral or L/C Cash Collateral (see below for definitions of ABL Priority Collateral and L/C Cash Collateral),

including 100% of the stock of material U.S. subsidiaries and 65% of the stock of material foreign subsidiaries (the “Term Loan Priority Collateral”) and (ii) a third priority lien on the ABL Priority Collateral and L/C Cash Collateral. The Term Loan Credit Agreement limits, among other things, the ability of the Company and its Restricted Subsidiaries (as defined in the Term Loan Credit Agreement) to (i) incur indebtedness, (ii) incur or create liens, (iii) dispose of assets, (iv) make restricted payments and (v) make ~~investments. The Term Loan Credit Agreement does not include a financial maintenance covenant or any subjective acceleration clauses~~. ~~The Term Loan Credit Agreement does contain~~investments, and also contains customary affirmative covenants including delivery of certain of the Company’s financial statements and customary event of default provisions, including a cross-default provision that would give rise to an event of default if there is a default under or acceleration of “Material Indebtedness”. Material Indebtedness includes obligations having a principal amount of at least $25 million and obligations under the Asset Based Loan Facility or Letter of Credit Facility.

~~On February 26, 2021, in connection with the execution of the~~set forth therein. The Term Loan Credit Agreement ~~the Company entered into~~does not include a letter agreement with KLIM (the “Board Rights Agreement”). Pursuant to the Board Rights Agreement, the Company’s Board of Directors (“Board”) appointed an individual designated by KLIM as a member of the Board effective April 1, 2021. The individual appointed was elected to serve a ~~one-year~~ term at the annual meeting on May 19, 2021. KLIM has the right to nominate one director at each annual or special meeting of the Company’s shareholders until the third anniversary of the execution of the Board Rights Agreement or until KLIM ceases to hold at least 50% of the original principal amount of the Term Loans and commitments under the Term Loan Credit Agreement, whichever is earlier.financial maintenance covenant.

Until KLIM ceases to hold at least 50% of the original principal amount of the Term Loans and commitments under the Term Loan Credit Agreement, at any time that KLIM’s designated director is not serving on the Board, KLIM will have the right to designate a non-voting observer to the Board. Such observer will have the right to attend meetings of the Board and, under certain circumstances, committees and subcommittees of the Board and to receive information and materials made available to the Board, in each case, subject to certain restrictions and exceptions.2021 Convertible Notes

On February 26, 2021, the Company ~~and the Term Loan Lenders (the “Buyers”),~~ entered into a Securities Purchase Agreement with certain funds affiliated with Kennedy Lewis Investment Management LLC (“KLIM”) as lenders (the

~~“Securities Purchase Agreement”~~ “Buyers”) pursuant to which the Company sold to the Buyers (i) an aggregate of 1,000,000 shares (the “Purchased Shares”) of the Company’s common stock (“Common Stock”) for a purchase price of $10.00 in cash per share for an aggregate purchase price of $10 million and (ii) $25 million aggregate principal amount of the Company’s newly issued 5.0% unsecured convertible promissory notes due May 28, 2026 (the “Convertible Notes”) in a private placement transaction. ~~The issuance and sale of the Purchased Shares and Convertible Notes were consummated on February 26, 2021.~~

The Convertible Notes bear interest at a rate of 5.0% per annum, which will be payable in cash on the maturity date and in additional shares of Common Stock on any conversion date. The payment of interest only at the maturity date has the same effect as delivering additional debt instruments to the Holders of the Convertible Notes and therefore is considered PIK. ~~Therefore,~~ PIK ~~will be~~is being added to the carrying value of the debt through the ~~term and interest~~term. Interest expense ~~will be~~is being recorded using the effective interest method. The maturity date of the Convertible Notes is May 28, 2026.

The Buyers ~~will~~ have the right to elect at any time to convert the Convertible Notes into shares of Common Stock at an initial conversion rate equal to 100 shares of Common Stock per each $1,000 principal amount of the Convertible Notes (based on an initial conversion price equal to $10.00 per share of Common Stock). The conversion rate and conversion price will be subject to certain customary anti-dilution adjustments.

If the closing price of the Common Stock equals or exceeds $14.50 (subject to adjustment in the same manner as the conversion price) for 45 trading days within any period of 60 consecutive trading days, the Company will have the right to cause the mandatory conversion of the Convertible Notes into shares of Common Stock.

In the event of certain fundamental transactions, the Buyers will have the right, within a period of 30 days following the occurrence of such transaction (“Holder Fundamental Transaction Election Period”), to elect to either require prepayment of the Convertible Notes at par plus accrued and unpaid interest or convert all or a portion of the Convertible Notes into shares of Common Stock at the conversion rate then in effect plus any additional shares based on the price per share of Common Stock in connection with the fundamental transaction, or to receive the shares of a successor entity, if any.

The Convertible Notes were considered more akin to a debt-type instrument and the economic characteristics and risks of the embedded conversion features are not considered clearly and closely related to the Convertible Notes. Accordingly, these embedded features were bifurcated from the Convertible Notes and separately accounted for on a combined basis at fair value as a single derivative liability. KodakCompany allocated $12 million of the net proceeds received to a derivative liability based on the aggregate fair value of the embedded features on the date of issuance which reduced the net carrying value of the Convertible Notes. The derivative is being accounted for at fair value with subsequent changes in the fair value being reported as part of Other (income) charges, net in the Consolidated Statement of Operations. The fair value of the Convertible Notes embedded derivative ~~as of September~~at both June 30, 2022 and December 31, 2021 was a liability of $7$4 million and is included in Other long-term liabilities in the accompanying Consolidated Statement of Financial Position. Refer to Note ~~20,~~18, “Financial Instruments” for information on the valuation of the derivative.

The carrying value of the Convertible Notes at ~~September~~June 30, 2022 and December 31, 2021 ~~and the time of issuance~~ was ~~$14~~$16 million and ~~$13~~$15 million, ~~($25~~respectively. The Convertible Notes unamortized discount at June 30, 2022 and December 31, 2021 was $10 million ~~aggregate gross proceeds less $12~~and $11 million, ~~allocated to the derivative liability),~~ respectively. The estimated fair value of the Convertible Notes as of ~~September~~June 30, ~~2021~~2022 was ~~$22~~$16 million (Level 3). The carrying value is being accreted to the aggregate principal amount using the effective interest method from the date of issuance through the maturity date.

On February 26, 2021, the Company and the Buyers entered into a Registration Rights Agreement (the “Securities Registration Rights Agreement”) providing the Buyers with registration rights in respect of the Purchased Shares and the Common Stock issuable upon conversion of the Convertible Notes. The Securities Registration Rights Agreement contains other customary terms and conditions, including certain customary indemnification obligations; however, the Securities Registration Rights Agreement does not obligate the Company to facilitate an underwritten offering of the registered Common Stock by the Buyers.

On February 26, 2021, the Company and the Subsidiary Guarantors entered into an amendment to the Amended and Restated Credit Agreement, dated as of May 26, 2016 (the “ABL Credit Agreement” and, as amended in 2021, the “Amended ABL Credit Agreement”), among the Company, the Subsidiary Guarantors, the lenders party thereto, Bank of America, N.A., as agent (the “Agent”), and Bank of America, N.A. and JPMorgan Chase Bank, N.A., as arrangers, with the Agent and the Required Lenders. Each of the capitalized and undefined terms has the meaning ascribed to such term in the ABL Credit Agreement.

The Amended ABL Credit Agreement amends the ABL Credit Agreement to, among other things, (i) extend the maturity date to February 26, 2024 or the date that is 90 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s Term Loans, Convertible Notes, Series B Preferred Stock, Series C Preferred Stock or any refinancings of any of the foregoing and (ii) decrease the aggregate amount of commitments from $110 million to $90 million. Commitments under the Amended ABL Credit Agreement continue to be able to be used in the form of revolving loans or letters of credit. The Company had issued approximately $42 million letters of credit under the Amended ABL Credit Agreement as of September 30, 2021 and $90 million letters of credit under the ABL Credit Agreement as of December 31, 2020.

The revolving loans bear interest at the rate of LIBOR plus 3.50%-4.00% per annum (subject to provisions providing for a replacement benchmark rate upon the discontinuation of LIBOR) or a floating Base Rate (as defined in the Amended ABL Credit Agreement) plus 2.50%-3.00% per annum, based on Excess Availability (as defined in the Amended ABL Credit Agreement). The Company will pay an unused line fee of 37.5-50 basis points per annum, depending on whether the unused portion of the maximum amount available is less than or equal to 50% or greater than 50%, respectively. The Company will pay a letter of credit fee of 3.50%-4.00% per annum, based on Excess Availability, on issued and outstanding letters of credit, in addition to a fronting fee of 25 basis points on such letters of credit.

Obligations under the Amended ABL Credit Agreement continue to be secured by: (i) a first priority lien on assets of the Company and the Subsidiary Guarantors constituting cash (other than L/C Cash Collateral, as defined below), accounts receivable, inventory, machinery and equipment and certain other assets (the “ABL Priority Collateral”) and (ii) a second priority lien on substantially all assets of the Company and the Subsidiary Guarantors (subject to certain exceptions) other than the ABL Priority Collateral, including the L/C cash collateral and 100% of the stock of material U.S. subsidiaries and 65% of the stock of material foreign subsidiaries.

The Amended ABL Credit Agreement continues to limit, among other things, the ability of the Company and its Restricted Subsidiaries (as defined in the Amended ABL Credit Agreement) to (i) incur indebtedness, (ii) incur or create liens, (iii) dispose of assets, (iv) make restricted payments and (v) make investments. The Amended ABL Credit Agreement leaves in place customary affirmative covenants, including delivery of certain of the Company’s financial statements set forth therein.

Under the Amended ABL Credit Agreement the Company is required to maintain Minimum Liquidity of at least $80 million, which is tested at the end of each quarter. Minimum Liquidity was $263 million at September 30, 2021. If Minimum Liquidity falls below $80 million an Event of Default would occur and the Agent has the right to declare the obligation of each Lender to make Revolving Loans and of the Issuing Banks to issue Letters of Credit to be terminated, and declare the Revolving Loans, all interest thereon and all other amounts payable under the Amended ABL Credit Agreement to be due and payable.

Under both the Amended ABL Credit Agreement and the ABL Credit Agreement the Company is required to maintain Excess Availability above 12.5% of lender commitments ($11.25 million and $13.75 million as of September 30, 2021 and December 31, 2020, respectively), which is tested at the end of each month. Excess Availability was $39 million and $20 million as of September 30, 2021 and December 31, 2020, respectively. If Excess Availability falls below 12.5% of lender commitments a Fixed Charge Coverage Ratio Trigger Event would occur. During any Fixed Charge Coverage Ratio Trigger Event, the Company would be required to maintain a Fixed Charge Coverage Ratio of greater than or equal to 1.0 to 1.0. If Excess Availability falls below 12.5% of lender commitments, Kodak may, in addition to the requirement to be in compliance with the minimum Fixed Charge Coverage Ratio, become subject to cash dominion control. Since Excess Availability was greater than 12.5% of lender commitments at September 30, 2021 and December 31, 2020, Kodak was not required to have a minimum Fixed Charge Coverage Ratio of 1.0 to 1.0. The Amended ABL Credit Agreement also removed Eligible Cash from the Borrowing Base. Therefore, amounts funded into the Eligible Cash account will no longer increase Excess Availability for purposes of compliance reporting. As of December 31, 2020, to maintain Excess Availability of greater than 12.5% of lender commitments, Kodak funded $35 million to the Eligible Cash account held with the ABL Credit Agreement Administrative Agent, which was classified as Restricted Cash in the Consolidated Statement of Financial Position.

If Excess Availability falls below 12.5% of lender commitments and the Fixed Charge Coverage Ratio is less than 1.0 to 1.0, an Event of Default would occur and the Agent has the right to declare the obligation of each Lender to make Revolving Loans and of the Issuing Banks to issue Letters of Credit to be terminated, and declare the Revolving Loans, all interest thereon and all other amounts payable under the Amended ABL Credit Agreement to be due and payable.

On February 26, 2021, the Company and the Subsidiary Guarantors entered into a Letter of Credit Facility Agreement (the “L/C Facility Agreement”, and together with the Term Loan Credit Agreement and the Amended ABL Credit Agreement the “Credit Agreements”) among the Company, the Subsidiary Guarantors, the lenders party thereto (the “L/C Lenders”), Bank of America, N.A., as agent, and Bank of America, N.A., as issuing bank. Pursuant to the L/C Facility Agreement, the L/C Lenders committed to issue letters of credit on the Company’s behalf in an aggregate amount of up to $50 million, provided that the Company posts cash collateral in an amount greater than or equal to 103% of the aggregate amount of letters of credit issued and outstanding at any given time (the “L/C Cash Collateral”).

~~The term of the L/C Facility Agreement is three years, subject to the same automatic springing maturity as the Amended ABL Credit Agreement.~~ ~~The Company had issued approximately $44 million letters of credit under the~~ ~~L/C Facility~~ ~~Agreement as of September 30, 2021.~~ The balance on deposit in the L/C Cash Collateral account as of September 30, 2021 is approximately $45 million, of which $14 million was deposited into the L/C Cash Collateral account from proceeds of the financing transactions described herein and the remainder of which was cash collateral previously used to secure letters of credit under the ABL Credit Agreement. The L/C Facility Agreement has the same requirement to maintain Minimum Liquidity of $80 million as is contained in the Amended ABL Credit Agreement.

Redeemable convertible preferred stock was as ~~follows at September 30, 2021 and December 31, 2020:~~follows:

On ~~November 15, 2016,~~February 26, 2021 the Company ~~issued 2,000,000~~agreed to exchange the remaining 1 million shares of Series A Preferred Stock ~~for an aggregate purchase price of $200 million, or $100 per share, pursuant to a Series A Preferred Stock Purchase Agreement with~~held by Southeastern Asset Management, Inc. (“Southeastern”) and Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust, which are investment funds managed by Southeastern (such investment funds, collectively, the “Purchasers”), ~~dated November 7, 2016. The Company classified the Series A Preferred Stock as temporary equity in the Consolidated Statement of Financial Position.~~

On February 26, 2021 the Company entered into a Series A Preferred Stock Repurchase and Exchange Agreement (the “Repurchase and Exchange Agreement”) with Southeastern and the Purchasers. The Company repurchased 1 million shares of the Series A Preferred Stock under the terms of the Repurchase and Exchange Agreement for $100,641,667, representing the liquidation value of the Series A Preferred Stock plus accrued and unpaid dividends. In addition, the Company and the Purchasers agreed to exchange the remaining 1 million shares of Series A Preferred Stock held by the Purchasers for shares of the Company’s newly created 4.0% Series B Convertible Preferred Stock, no par value (the “Series B Preferred Stock”) on a one-for-one basis plus accrued and unpaid dividends ~~of $641,667. The exchange of shares of Series A Preferred Stock for shares of Series B Preferred Stock is a noncash financing activity.~~

Kodak allocated $43 million of the net proceeds from the issuance of the Series A Stock to a derivative liability based on the aggregate fair value of the embedded conversion features on the date of issuance, which reduced the net carrying value of the Series A Preferred Stock (see Note 20, “Financial Instruments”). The carrying value of the Series A Preferred Stock at the time of issuance, $155 million ($200 million aggregate gross proceeds less $43 million allocated to the derivative liability and $2 million in transaction costs), was being accreted to the mandatory redemption amount using the effective interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance through the mandatory redemption date, November 15, 2021.

The carrying value, including the fair value of the embedded derivative liability, of the Series A Preferred Stock prior to extinguishment approximated $203 million. Upon repurchase and exchange of the Series A Preferred Stock, Kodak recorded $8 million as a deemed dividend to Additional paid in capital in the Consolidated Statement of Financial Position, representing the difference between the fair value of consideration transferred and the carrying value of the Series A Preferred Stock.

~~The holders of Series A Preferred Stock were entitled to cumulative dividends payable quarterly in cash at a rate of 5.50% per annum.~~

The fair value of the Series B Preferred Stock at the time of issuance approximated $95 million. The Company has classified the Series B Preferred Stock as temporary equity in the Consolidated Statement of Financial Position.

On February 25, 2021, the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of the Company (the “Series B Certificate of Designations”) which established the designation, number of shares, rights, preferences and limitations of the Series B Preferred Stock which became effective upon filing. The ~~Series B Preferred Stock ranks senior to the Common Stock and~~ ~~pari passu~~ with the Series C Preferred Stock with respect to dividend rights and rights on liquidation, winding-up and dissolution. The Series B Preferred Stock has a liquidation preference of $100 per share, and the holders of Series B Preferred Stock are entitled to cumulative dividends payable quarterly in cash at a rate of 4.0% per annum. If dividends on any Series B Preferred Stock are in arrears for six or more consecutive or non-consecutive dividend periods, the holders of the Series B Preferred Stock will be entitled to nominate one director at the next annual shareholder meeting and all subsequent shareholder meetings until all accumulated dividends on such Series B Preferred Stock have been paid or set aside. Dividends owed on the Series B Preferred Stock have been declared and paid when due. ~~Holders of Series B Preferred Stock will have certain limited special approval rights, including with respect to the issuance of~~ ~~pari passu~~ ~~or senior equity securities of the Company.~~

Each share of Series B Preferred Stock is convertible, at the option of each holder at any time, into shares of Common Stock at the initial conversion rate of 9.5238 shares of Common Stock for each share of Series B Preferred Stock (equivalent to an initial conversion price of $10.50 per share of Common Stock). The initial conversion rate and the corresponding conversion price will be subject to certain customary anti-dilution adjustments. If a holder elects to convert any shares of Series B Preferred Stock during a specified period in connection with a fundamental change (as defined in the Series B Certificate of Designations), such holder can elect to have the conversion rate adjusted and can elect to receive a cash payment in lieu of shares for a portion of the shares. Such holder will also be entitled to a payment in respect of accumulated dividends. In addition, the Company will have the right to require holders to convert any shares of Series B Preferred Stock in connection with certain reorganization events in which case the conversion rate will be adjusted, subject to certain limitations.

The Company will have the right to cause the mandatory conversion of the Series B Preferred Stock into shares of Common Stock at any time after the initial issuance of the Series B Preferred Stock if the closing price of the Common Stock has equaled or exceeded $14.50 (subject to adjustment in the same manner as the conversion price) for 45 trading days within a period of 60 consecutive trading days.

The Company concluded that the Series B Preferred Stock is considered more akin to a debt-type instrument and that the economic characteristics and risks of the conversion option upon a fundamental change by the holder was not considered clearly and closely related to the Series B Preferred Stock. Accordingly, this embedded conversion feature was bifurcated from the Series B Preferred Stock and separately accounted for at fair value as a derivative. The Company allocated $1 million to the derivative liability based on the aggregate fair value of the embedded conversion feature on the date of issuance which reduced the original carrying value of the Series B Preferred Stock. The derivative is being accounted for at fair value with subsequent changes in the fair value being reported as part of Other (income) charges, net in the Consolidated Statement of Operations. The fair value of the Series B Preferred Stock embedded derivative as of ~~September~~both June 30, 2022 and December 31, 2021 was a liability of $1 million and is included in Other long-term liabilities in the accompanying Consolidated Statement of Financial Position. Refer to Note ~~20,~~18, “Financial Instruments” for information on the valuation of the derivative.

The carrying value of the Series B Preferred Stock ~~at the time of issuance, $93 million ($95 million fair value of Series B Preferred Stock on February 26, 2021 less $1 million allocated to the derivative liability and $1 million of transaction costs)~~ is being accreted to the mandatory redemption amount using the effective interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance through the mandatory redemption date, May 28, 2026.

If any shares of Series B Preferred Stock have not been converted prior to May 28, 2026 (the “Redemption Date”), the Company is required to redeem such shares at $100 per share plus the amount of accrued and unpaid dividends. As the Company concluded that the Series B Preferred Stock is considered more akin to a debt-type instrument, the redemption feature is considered to be clearly and closely related to the host contract and therefore was not required to be separated from the Series B Preferred Stock.

On February 26, 2021, the Company and GO EK Ventures IV, LLC (the “Investor”) entered into a Series C Preferred Stock Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company agreed to sell to the Investor, and the Investor agreed to purchase from the Company, an aggregate of 1,000,000 shares of the Company’s newly created 5.0% Series C Convertible Preferred Stock, no par value per share (the “Series C Preferred Stock”), for a purchase price of $100 per share, representing $100 million of gross proceeds to the Company. The initial issuance and sale of 750,000 shares ($75 million gross proceeds) closed on February 26, 2021, and the final issuance and sale of the remaining 250,000 shares ($25 million gross proceeds) closed on March 30, 2021 after expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The Investor is a fund managed by Grand Oaks Capital. ~~The Company intends to use the proceeds from the sale of the Series C Preferred Stock for general corporate purposes including the funding of growth initiatives.~~ The Company has classified the Series C Preferred Stock as temporary equity in the Consolidated Statement of Financial Position.

On February 25, 2021, the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of the Company (the “Series C Certificate of Designations”) which established the designation, number of shares, rights, preferences and limitations of the Series C Preferred Stock and became effective upon filing. The ~~Series C Preferred Stock ranks senior to the Common Stock and~~ ~~pari passu~~ with the Series B Preferred Stock with respect to dividend rights and rights on liquidation, winding-up and dissolution. The Series C Preferred Stock has an initial liquidation preference of $100 per share, and holders of Series C Preferred Stock are entitled to cumulative dividends payable quarterly ~~“in-kind”~~“in‐kind” in the form of additional shares of Series C Preferred Stock at a rate of 5.0% per annum. ~~If dividends~~Dividends owed on the Series C Preferred Stock ~~are not~~have been declared and ~~paid for any given fiscal quarter, the liquidation preference is automatically increased by the amount of such unpaid dividends.~~additional Series C shares issued when due. Holders of the Series C Preferred Stock ~~will~~are also be entitled to participate in any dividends paid on the Common Stock (other than stock dividends) on an as-converted basis, with such dividends on any shares of the Series C Preferred Stock being payable upon conversion of such shares of Series C Preferred Stock to Common Stock. ~~Dividends owed on the Series C Preferred Stock have been declared and additional Series C shares issued when due.~~

Holders of Series C Preferred Stock are entitled to vote together with the holders of the Common Stock as a single class, in each case, on an as-converted basis, except where a separate class vote is required by law. Holders of Series C Preferred Stock have certain limited special approval rights, including with respect to the issuance of ~~pari passu~~ ~~or senior equity securities of the Company.~~

Pursuant to the Purchase Agreement, the Investor has the right to nominate one director at each annual or special meeting of the Company’s shareholders until the earlier of the third anniversary of the execution of the Purchase Agreement and such time as the Investor and its Affiliates (as defined in the Purchase Agreement) do not hold at least a majority of the Series C Preferred Stock purchased under the Purchase Agreement. The Investor’s nominee pursuant to this right was elected at the Company’s annual meeting held on May 19, 2021 to serve a one-year term.

Each share of Series C Preferred Stock is convertible, at the option of each holder at any time, into shares of Common Stock at the initial conversion price of $10 per share of Common Stock. The initial conversion price and the corresponding conversion rate will be subject to certain customary anti-dilution adjustments and to proportional increase in the event the liquidation preference of the Series C Preferred Stock is automatically increased as described above. If a holder elects to convert any shares of Series C Preferred Stock during a specified period in connection with a fundamental change (as defined in the Series C Certificate of Designations), such holder can elect to have the conversion rate adjusted and can elect to receive a cash payment in lieu of shares for a portion of the shares of Common Stock. Such holder will also be entitled to a payment in respect of accumulated dividends and a payment based on the present value of all required remaining dividend payments through May 28, 2026, the mandatory redemption date. Such additional payments will be payable at the Company’s option in cash or in additional shares of Common Stock. In addition, the Company will have the right to require holders to convert any shares of Series C Preferred Stock in connection with certain reorganization events in which case the conversion rate will be adjusted, subject to certain limitations.

The Company will have the right to cause the mandatory conversion of the Series C Preferred Stock into shares of Common Stock (i) at any time after February 26, 2023 if the closing price of the Common Stock has equaled or exceeded 200% of the then-effective conversion price for 45 trading days within a period of 60 consecutive trading days, or (ii) at any time after February 26, 2024 if the closing price of the Common Stock has equaled or exceeded 150% of the then-effective conversion price for 45 trading days within a period of 60 consecutive trading days.

The Company concluded that the Series C Preferred Stock is considered more akin to a debt-type instrument and that the economic characteristics and risks of the conversion option upon a fundamental change by the holder is not considered clearly and closely related to the Series C Preferred Stock. Accordingly, this embedded conversion feature was bifurcated from the Series C Preferred Stock and separately accounted for as a derivative. The Company allocated $2 million of the net proceeds received to the derivative liability based on the aggregate fair value of the embedded conversion features on the dates of issuance which reduced the original carrying value of the Series C Preferred Stock. The derivative is being accounted for at fair value with subsequent changes in the fair value being reported as part of Other (income) charges, net in the Consolidated Statement of Operations. The fair value of the Series C Preferred Stock derivative as of ~~September~~June 30, 2022 and December 31, 2021 was a liability of $1 million and $2 million, respectively, and is included in Other long-term liabilities in the accompanying Consolidated Statement of Financial Position. Refer to Note ~~20,~~18, “Financial Instruments” for information on the valuation of the derivative.

The carrying value of the Series C Preferred Stock ~~at the time of issuance, $97 million ($100 million aggregate gross proceeds less $2 million allocated to the derivative liability and $1 million in transaction costs)~~ is being accreted to the mandatory redemption amount using the effective interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance through the mandatory redemption date.

If any shares of Series C Preferred Stock have not been converted prior to the Redemption Date, the Company is required to redeem such shares at $100 per share plus the amount of accrued and unpaid dividends thereon; provided that the holders of the Series C Preferred Stock have the right to extend such redemption date by up to two years. As the Company concluded that the Series C Preferred Stock is considered more akin to a debt-type instrument, the redemption feature is considered to be clearly and closely related to the host contract and therefore was not required to be separated from the Series C Preferred Stock.

On February 26, 2021, the Company and the Investor entered into a Registration Rights Agreement (the “Series C Registration Rights Agreement”) which provides the Investor with customary registration rights in respect of the shares of Common Stock issuable upon conversion of the Series C Preferred Stock. The Series C Registration Rights Agreement contains other customary terms and conditions, including certain customary indemnification obligations.

Income recognized on operating lease arrangements for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 is presented below. Income recognized for sales-type lease arrangements ~~is $1 million and $2 million for the three and nine months ended September 30, 2021, respectively and $0 million~~ for both the three and ~~nine~~six months ended ~~September~~June 30, ~~2020.~~2022 was $0 million and for the three and six months ended June 30, 2021 was $0 million and $1 million, respectively.

As of ~~September~~June 30, ~~2021,~~2022, the Company had outstanding letters of credit of ~~$42~~$46 million and $44 million issued under the Amended ABL Credit Agreement and the L/C Facility Agreement, respectively, as well as bank guarantees and letters of credit of $2 million, surety bonds in the amount of $29 million, and restricted cash of ~~$71~~$64 million, primarily related to cash collateral for the outstanding letters of credit under the L/C Facility Agreement, to ensure payment of possible casualty and workers’ compensation claims, legal contingencies, hedging activities, environmental liabilities, rental payments and to support various customs, tax and trade activities.

Kodak routinely assesses all these matters as to the probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. As of ~~September~~June 30, ~~2021, the~~2022, Kodak’s Brazilian Operations maintained accruals of approximately $2 million for claims aggregating approximately $118 million inclusive of interest and penalties where appropriate. The unreserved portion of ~~these contingencies,~~the indirect taxes, civil litigation and disputes associated with former employees and contract labor claims, inclusive of any related interest and penalties, for which there was at least a reasonable possibility that a loss may be incurred, amounted to approximately $4 million.

In connection with assessments in Brazil, local regulations may require Kodak’s Brazilian operations to post security for a portion of the amounts in dispute. As of ~~September~~June 30, ~~2021,~~2022, Kodak’s Brazilian operations have posted security composed of $3$5 million of pledged cash reported within Restricted cash in the Consolidated Statement of Financial Position and liens on certain Brazilian assets with a net book value of approximately ~~$41~~$42 million. Generally, any encumbrances on the Brazilian assets would be removed to the extent the matter is resolved in Kodak's favor.

On July 28, 2020, the U.S. International Development Finance Corporation (the “DFC”) announced (the “DFC Announcement”) the signing of a non-binding letter of interest to provide a subsidiary of the Company with a potential $765 million loan (the “DFC Loan”) to support the launch of Kodak Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs (the “DFC Pharmaceutical Project”).

On August 13, 2020 Tiandong Tang commenced a class action lawsuit against the Company, its Executive Chairman and Chief Executive Officer and its Chief Financial Officer in Federal District Court in the District of New Jersey, and on August 26, 2020 Jimmie A. McAdams and Judy P. McAdams commenced a class action lawsuit against the Company and its Executive Chairman and Chief Executive Officer in Federal District Court in the Southern District of New York (collectively, the “Securities Class Actions”). The Securities Class Actions seek damages and other relief based on alleged violations of federal securities laws in the context of the ~~DFC Announcement~~U.S. International Development Finance Corporation (the “DFC”) announcement (the “DFC Announcement”) of the signing of a non-binding letter of interest to provide a subsidiary of the Company with a potential ~~DFC Loan and DFC~~$765 million loan (the “DFC Loan”) to support the launch of Kodak Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs (the “DFC Pharmaceutical ~~Project.~~Project”) on July 28, 2020. The Securities Class Actions were transferred to the Federal District Court for the Western District of New York and were consolidated into a single proceeding (the “Consolidated Securities Class Action”) on June 22, 2021. Les Investissements Kiz Inc. and UAT Trading Service, Inc. were appointed by the court to serve as lead plaintiff for the Consolidated Securities Class Action on August 2, 2021, and the lead plaintiff filed an amended consolidated complaint on October 1, 2021 which added Kodak’s General Counsel and current and former members of its Board of Directors as additional defendants. The Company and individual defendants filed motions to dismiss the Consolidated Securities Class Action on December 14, 2021. The lead plaintiff filed an opposition to the motions to dismiss on February 28, 2022, and the Company and the individual defendants filed responses to the plaintiff’s opposition on April 6, 2022. A hearing with respect to the motions to dismiss was held on August 3, 2022. The Company intends to continue to vigorously defend itself against the Consolidated Securities Class Action.

On December 29, 2020 Robert Garfield commenced a class action lawsuit against the Company and current and former members of its Board of Directors in the Superior Court of Mercer County, New Jersey seeking equitable relief and damages in favor of the Company based on alleged breaches of fiduciary duty by the Company’s Board of Directors associated with alleged false and misleading proxy statement disclosures (including the successor New York lawsuit discussed below, the “Fiduciary Class Action”). The Company and each of the individual defendants filed motions to dismiss the Fiduciary Class Action on April 13, 2021. The plaintiff in the Fiduciary Class Action voluntarily dismissed the Fiduciary Class Action without prejudice on May 26, 2021 and filed a lawsuit substantially similar to the dismissed New Jersey lawsuit in the Supreme Court of the State of New York in Monroe County on October 27, 2021, this time on behalf of a purported class of beneficial and record owners of stock of the Company as of March 26, 2020 who continue to own such stock through the present. The Company ~~intends~~and individual defendants filed motions to ~~vigorously defend itself against~~dismiss the Fiduciary Class ~~Action.~~Action on January 19, 2022. The plaintiff filed an opposition to the motions to dismiss on March 28, 2022, and the Company and the individual defendants filed responses to the plaintiff’s opposition on May 9, 2022. A hearing with respect to the motions to dismiss was held on May 24, 2022, and the lawsuit was dismissed with prejudice on June 10, 2022. The dismissal was not appealed during the applicable appeal period as a result of which the lawsuit is concluded.

On September 2, 2021 Herbert Silverberg, another person making a Derivative Demand (“Silverberg”), commenced a derivative lawsuit on behalf of the Company against one current and one former director of the Company and the Company as a nominal defendant in the Federal District Court for the Western District of New York seeking damages and equitable relief on a basis overlapping with the State Derivative Lawsuit and alleged proxy statement misrepresentations and omissions.

On October 4, 2021 Peters commenced a derivative lawsuit on behalf of the Company against the same parties named in the State Derivative Lawsuit in the Federal District Court for the Western District of New York seeking damages and equitable relief on a basis overlapping with the State Derivative Lawsuit and alleged violations of Section 10(b) of the Exchange Act. ~~A process is underway to consolidate~~The Federal derivative lawsuits filed by Silverberg and Peters were consolidated into a single proceeding (the “Federal Derivative Lawsuit”) on January 18, 2022, and Peters was appointed as lead plaintiff in the Federal Derivative Lawsuit. An amended consolidated complaint combining the allegations contained in the Federal derivative lawsuits filed by Silverberg and Peters ~~(the “Federal Derivative Lawsuits”) and appoint a lead plaintiff~~was filed in the Federal Derivative ~~Lawsuits.~~ Lawsuit on February 16,

2022, and the Company and individual defendants filed motions to dismiss or, in the alternative in the case of the Company, for summary judgment on April 15, 2022. Limited discovery in the case is ongoing.

Additional shareholder derivative lawsuits may be brought based on the other Derivative Demands (any such lawsuits, collectively with the State Derivative Lawsuit, the Federal Derivative ~~Lawsuits~~Lawsuit and the Fiduciary Class Action, the “Fiduciary Matters”). The Company, acting through a Special Committee of Independent Directors, previously determined that there was no merit to the claims alleged by the Derivative Demands made through the time of its determination (except with respect to the charitable contribution, which was not fully considered by the Special Committee). See the Company’s Current Report on Form ~~8-K~~8‐K filed with the SEC on September 16, 2020.

The Company, acting through a separate Special Litigation Committee of Independent Directors, concurred with the first Special Committee’s findings and further concluded it is not in the Company’s interest to bring or allow any other shareholder to assert any of the claims alleged by the State Derivative Lawsuit or Federal Derivative ~~Lawsuits~~Lawsuit (with the exception of the Peters claim purportedly arising under Section 10(b) of the Exchange Act, which was not addressed as no demand was made with respect to such claim). The second Special Litigation Committee will carefully review any other additional complaints constituting Fiduciary Matters which may be filed.

The DFC Announcement has also prompted investigations by several congressional committees, the SEC and the New York Attorney General’s office. The Company ~~is cooperating with the~~has cooperated in those investigations.

As previously reported, the Attorney General of the State of New York (the “NYAG”) has threatened to file a lawsuit against the Company and its Chief Executive Officer alleging violations of New York State’s Martin Act (the “Threatened Claim”). In connection with the Threatened Claim, on June 15, 2021 the Supreme Court of the State of New York in New York County issued an order providing for additional document production by the Company to the NYAG and the taking by the NYAG of investigative testimony of the Company’s Chief Executive Officer and General Counsel. The Company has completed its document production and its officers ~~have~~ provided the testimony as contemplated by such ~~order.~~order on October 8, 2021 and October 1, 2021, respectively. The Company had discussions with the NYAG regarding a potential resolution of the Threatened Claim in the spring of 2022, but those discussions did not result in a resolution. If the Threatened Claim is not resolved and is ultimately brought by the NYAG, the Company intends to vigorously defend itself against the Threatened ~~Claim should it be filed.~~Claim.

In addition, Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. Kodak is also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s ~~products and claims arising out of Kodak’s licensing its brand.~~products. These matters are in various stages of investigation and litigation and are being vigorously defended. Based on information currently available, Kodak does not believe that it is probable that the outcomes in ~~any of~~ these various matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations. Litigation is inherently unpredictable, and judgments could be rendered or settlements entered that could adversely affect Kodak’s operating results or cash flows in a particular period. Kodak routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

In connection with the settlement of certain of the Company’s historical environmental liabilities at Eastman Business Park, a more than 1,200-acre technology center and industrial complex in Rochester, New York, in the event the historical liabilities exceed $99 million, the Company will become liable for 50% of the portion above $99 million with no limitation to the maximum potential future payments. There is 0 liability recorded for this guarantee.

Kodak offers its customers extended warranty arrangements that are generally one year, but may range from three months to six years after the original warranty period. The change in Kodak’s deferred revenue balance in relation to these extended warranty and maintenance arrangements from December 31, ~~2020~~2021 to ~~September~~June 30, ~~2021,~~2022, which is reflected in Other current liabilities in the accompanying Consolidated Statement of Financial Position, was as follows:

The following tables present revenue disaggregated by major product, portfolio summary and ~~geography.~~

Three Months Ended
June 30, 2022

(in millions)	Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Plates, inks and other consumables	$	165	$	17	$	7	$	—	$	—	$	189
Ongoing service arrangements ⁽¹⁾		19		33		3		—		—		55
Total annuities		184		50		10		—		—		244
Equipment & software		10		8		—		—		—		18
Film and chemicals		—		—		50		—		—		50
Other⁽²⁾		—		—		1		4		4		9
Total	$	194	$	58	$	61	$	4	$	4	$	321


Six Months Ended
June 30, 2022

(in millions)	Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Plates, inks and other consumables	$	310	$	33	$	14	$	—	$	—	$	357
Ongoing service arrangements ⁽¹⁾		38		67		5		—		—		110
Total annuities		348		100		19		—		—		467
Equipment & software		18		14		—		—		—		32
Film and chemicals		—		—		95		—		—		95
Other ⁽²⁾		—		—		1		8		8		17
Total	$	366	$	114	$	115	$	8	$	8	$	611

Three Months Ended

September 30, 2021

(in millions)

Traditional
Printing

Digital
Printing

Advanced
Materials
and
Chemicals

Brand

All Other

Total

Plates, inks and other
   consumables

$
134

$
18

$
7

$
—

$
—

$
159

Ongoing service
   arrangements ⁽¹⁾

20

33

1

—

—

54

Total annuities

154

51

8

—

—

213

Equipment & software

12

7

—

—

—

19

Film and chemicals

—

—

47

—

—

47

Other⁽²⁾

—

—

—

4

4

8

Total

$
166

$
58

$
55

$
4

$
4

$
287

Nine Months Ended

September 30, 2021

(in millions)

Traditional
Printing

Digital
Printing

Advanced
Materials
and
Chemicals

Brand

All Other

Total

Plates, inks and other
   consumables

$
389

$
50

$
17

$
—

$
—

$
456

Ongoing service
   arrangements ⁽¹⁾

60

101

4

—

—

165

Total annuities

449

151

21

—

—

621

Equipment & software

34

33

—

—

—

67

Film and chemicals

—

—

133

—

—

133

Other ₍₂₎

—

—

1

10

11

22

Total

$
483

$
184

$
155

$
10

$
11

$
843

Three Months Ended	Three Months Ended													Three Months Ended
September 30, 2020
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Plates, inks and other consumables		$	114	$	15	$	5	$	—	$	—	$	134		$	135	$	16	$	5	$	—	$	—	$	156
Ongoing service arrangements ⁽¹⁾			20		33		1		—		—		54			20		33		2		—		—		55
Total annuities			134		48		6		—		—		188			155		49		7		—		—		211
Equipment & software			12		8		—		—		—		20			14		13		—		—		—		27
Film and chemicals			—		—		36		—		—		36			—		—		47		—		—		47
Other⁽²⁾			—		—		2		3		3		8			—		—		—		3		3		6
Total		$	146	$	56	$	44	$	3	$	3	$	252		$	169	$	62	$	54	$	3	$	3	$	291

Nine Months Ended
September 30, 2020
Six Months Ended														Six Months Ended
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Plates, inks and other consumables		$	330	$	45	$	18	$	—	$	—	$	393		$	256	$	33	$	10	$	—	$	—	$	299
Ongoing service arrangements ⁽¹⁾			60		97		2		—		—		159			40		67		3		—		—		110
Total annuities			390		142		20		—		—		552			296		100		13		—		—		409
Equipment & software			29		31		—		—		—		60			21		26		—		—		—		47
Film and chemicals			—		—		97		—		—		97			—		—		86		—		—		86
Other⁽²⁾			—		—		7		8		8		23			—		—		1		6		7		14
Total		$	419	$	173	$	124	$	8	$	8	$	732		$	317	$	126	$	100	$	6	$	7	$	556

Three Months Ended	Three Months Ended													Three Months Ended
September 30, 2021
June 30, 2022														June 30, 2022

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Growth engines ⁽¹⁾		$	56	$	32	$	—	$	—	$	—	$	88		$	71	$	34	$	1	$	—	$	—	$	106
Strategic other businesses ⁽²⁾			110		14		55		4		4		187			123		13		60		4		4		204
Planned declining businesses ⁽³⁾			—		12		—		—		—		12			—		11		—		—		—		11
Total		$	166	$	58	$	55	$	4	$	4	$	287		$	194	$	58	$	61	$	4	$	4	$	321

Nine Months Ended
September 30, 2021
Six Months Ended														Six Months Ended
June 30, 2022														June 30, 2022

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Growth engines ⁽¹⁾		$	156	$	105		—		—	$	—	$	261		$	137	$	65	$	1	$	—	$	—	$	203
Strategic other businesses ⁽²⁾			327		42		155		10		11		545			229		26		114		8		8		385
Planned declining businesses ⁽³⁾			—		37		—		—		—		37			—		23		—		—		—		23
Total		$	483	$	184	$	155	$	10	$	11	$	843		$	366	$	114	$	115	$	8	$	8	$	611

Three Months Ended	Three Months Ended													Three Months Ended
September 30, 2020
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Growth engines⁽¹⁾		$	41	$	32	$	1	$	—	$	—	$	74		$	53	$	36	$	—	$	—	$	—	$	89
Strategic other businesses ⁽²⁾			105		12		42		3		3		165			116		15		54		3		3		191
Planned declining businesses ⁽³⁾			—		12		1		—		—		13			—		11		—		—		—		11
Total		$	146	$	56	$	44	$	3	$	3	$	252		$	169	$	62	$	54	$	3	$	3	$	291

Nine Months Ended
September 30, 2020
Six Months Ended														Six Months Ended
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
Growth engines⁽¹⁾		$	112	$	98	$	2	$	—	$	—	$	212		$	100	$	73	$	—	$	—	$	—	$	173
Strategic other businesses ⁽²⁾			307		37		115		8		8		475			217		28		100		6		7		358
Planned declining businesses ⁽³⁾			—		38		7		—		—		45			—		25		—		—		—		25
Total		$	419	$	173	$	124	$	8	$	8	$	732		$	317	$	126	$	100	$	6	$	7	$	556

Three Months Ended	Three Months Ended													Three Months Ended
September 30, 2021
June 30, 2022														June 30, 2022

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
United States		$	36	$	25	$	40	$	4	$	4	$	109		$	44	$	29	$	46	$	4	$	4	$	127
Canada			3		2		—		—		—		5			3		2		1		—		—		6
North America			39		27		40		4		4		114			47		31		47		4		4		133
Europe, Middle East and Africa			75		21		4		—		—		100			98		19		5		—		—		122
Asia Pacific			44		9		11		—		—		64			42		7		9		—		—		58
Latin America			8		1		—		—		—		9			7		1		—		—		—		8
Total		$	166	$	58	$	55	$	4	$	4	$	287		$	194	$	58	$	61	$	4	$	4	$	321

Nine Months Ended
September 30, 2021
Six Months Ended														Six Months Ended
June 30, 2022														June 30, 2022

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
United States		$	101	$	78	$	111	$	10	$	11	$	311		$	80	$	55	$	86	$	8	$	8	$	237
Canada			9		7		1		—		—		17			6		4		1		—		—		11
North America			110		85		112		10		11		328			86		59		87		8		8		248
Europe, Middle East and Africa			219		62		12		—		—		293			182		38		9		—		—		229
Asia Pacific			132		34		31		—		—		197			83		15		19		—		—		117
Latin America			22		3		—		—		—		25			15		2		—		—		—		17
Total		$	483	$	184	$	155	$	10	$	11	$	843		$	366	$	114	$	115	$	8	$	8	$	611

Three Months Ended	Three Months Ended													Three Months Ended
September 30, 2020
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
United States		$	29	$	25	$	30	$	3	$	3	$	90		$	36	$	26	$	38	$	3	$	3	$	106
Canada			5		3		—		—		—		8			4		2		1		—		—		7
North America			34		28		30		3		3		98			40		28		39		3		3		113
Europe, Middle East and Africa			64		19		4		—		—		87			76		22		5		—		—		103
Asia Pacific			41		8		10		—		—		59			46		11		10		—		—		67
Latin America			7		1		—		—		—		8			7		1		—		—		—		8
Total		$	146	$	56	$	44	$	3	$	3	$	252		$	169	$	62	$	54	$	3	$	3	$	291

Nine Months Ended
September 30, 2020
Six Months Ended														Six Months Ended
June 30, 2021														June 30, 2021

(in millions)		Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total			Traditional Printing		Digital Printing		Advanced Materials and Chemicals		Brand		All Other		Total
United States		$	90	$	77	$	85	$	8	$	8	$	268		$	65	$	53	$	71	$	6	$	7	$	202
Canada			11		6		1		—		—		18			6		5		1		—		—		12
North America			101		83		86		8		8		286			71		58		72		6		7		214
Europe, Middle East and Africa			181		61		9		—		—		251			144		41		8		—		—		193
Asia Pacific			116		26		29		—		—		171			88		25		20		—		—		133
Latin America			21		3		—		—		—		24			14		2		—		—		—		16
Total		$	419	$	173	$	124	$	8	$	8	$	732		$	317	$	126	$	100	$	6	$	7	$	556

The timing of revenue recognition, billings and cash collections results in billed trade receivables, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) in the Consolidated Statement of Financial Position. The contract assets are transferred to trade receivables when the rights to consideration become unconditional. The amount recorded for contract assets at ~~both September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was $2$1 million and $3 million, respectively, and is reported in Other current assets in the Consolidated Statement of Financial Position. The contract liabilities primarily relate to prepaid service contracts, upfront payments for certain equipment purchases or prepaid royalties on intellectual property arrangements. The amounts recorded for contract liabilities at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 were ~~$58~~$61 million and ~~$64~~$57 million, respectively, in the Consolidated Statement of Financial Position, of which ~~$43~~$48 million and ~~$47~~$43 million are reported in Other current liabilities, respectively, and ~~$15~~$13 million and ~~$17~~$14 million ~~respectively,~~ are reported in Other long-term liabilities, ~~in the Consolidated Statement of Financial Position.~~respectively.

Revenue recognized for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 that was included in the contract liability balance at the beginning of the year was $9$12 million and ~~$34~~$29 million, respectively, in ~~2021, respectively,~~2022 and $4$6 million and ~~$35~~$31 million, respectively, in ~~2020, respectively,~~2021 and primarily represented revenue from prepaid service contracts and equipment revenue recognition. Contract liabilities as of ~~September~~June 30, 2022 included $22 million and $33 million of cash payments received during the three and six months ended June 30, 2022 respectively. Contract liabilities as of June 30, 2021 included ~~$19~~$22 million and $26 million of cash payments received during the three and ~~nine~~six months ended ~~September~~June 30, 2021, ~~respectively. Contract liabilities as of September 30, 2020 included $21 million and $31 million of cash payments received during the three and nine months ended September 30, 2020,~~ respectively.

Kodak does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less or for which revenue is recognized at the amount to which Kodak has the right to invoice for services performed. Performance obligations with an original expected length of greater than one year generally consist of deferred service contracts, operating leases and licensing arrangements. As of ~~September~~June 30, ~~2021,~~2022, there was approximately ~~$70~~$65 million of unrecognized revenue from unsatisfied performance obligations. Approximately ~~10%~~15% of the revenue from unsatisfied performance obligations is expected to be recognized in the remainder of ~~2021,~~2022, 30% in ~~2022, 20%~~2023, 30% in ~~2023, 15% in~~the two-year period 2024 through 2025 and 25% thereafter.

For the three months ended ~~September~~June 30, ~~2021,~~2022, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses, (2) the results from operations in jurisdictions outside the U.S. and (3) a benefit associated with foreign withholding taxes on undistributed earnings.

For the ~~nine~~six months ended ~~September~~June 30, 2022, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses, (2) the results from operations in jurisdictions outside the U.S., (3) a benefit associated with foreign withholding taxes on undistributed earnings and (4) changes in audit reserves, including a settlement with a taxing authority in a location outside the U.S.

During the quarter ended March 31, 2022, Kodak agreed to terms with a taxing authority outside the U.S. and settled open tax audits for years 2015 through 2018. This settlement included a cash payment of $2 million which is reflected in the provision for taxes in the year-to-date period, and a decrease in net deferred tax assets of $2 million which was fully offset by a corresponding change in the valuation allowance.

For the three months ended June 30, 2021, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses and (2) the results from operations in jurisdictions outside the U.S.

For the six months ended June 30, 2021, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses, (2) the results from operations in jurisdictions outside the U.S., (3) a benefit associated with foreign withholding taxes on undistributed earnings and (4) changes in audit reserves, including a settlement with a taxing authority in a location outside the U.S.

During the quarter ended March 31, 2021, Kodak agreed to terms with a taxing authority outside the U.S. and settled open tax audits for years ~~through~~prior to and including 2014. For these years, Kodak originally recorded liabilities for unrecognized tax positions totaling $3 million (plus interest of approximately $4 million), which were substantially offset by pre-paid assets.

For the three months ended September 30, 2020, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses and (2) the results from operations in jurisdictions outside the U.S.

For the nine months ended September 30, 2020, the difference between Kodak’s effective tax rate and the U.S. statutory rate of 21.0% is primarily attributable to: (1) a provision of $167 million associated with the establishment of valuation allowances in certain outside U.S. jurisdictions, (2) the impact related to existing valuation allowances associated with changes in net deferred tax assets from current earnings and losses, (3) the results from operations in jurisdictions outside the U.S., (4) a provision associated with foreign withholding taxes on undistributed earnings and (5) changes in audit reserves.

Kodak establishes valuation allowances for deferred income tax assets in accordance with U.S. GAAP, which provides that such valuation allowances shall be established unless realization of the income tax benefits is more likely than not. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. At each reporting period, Kodak considers the scheduled reversal of deferred tax liabilities and assets, available taxes in carryback periods, tax planning strategies and projected future taxable income in making this assessment.

As of March 31, 2020, Kodak determined that it was more likely than not that deferred tax assets outside the U.S. which were not offset with valuation allowances as of March 31, 2020 would not be realized due to reductions in estimates of future profitability as a result of the COVID-19 pandemic in locations outside the U.S. Accordingly, Kodak recorded a provision of $167 million associated with the establishment of a valuation allowance on those deferred tax assets.

Additionally, on February 21, 2020, Kodak agreed to terms with the IRS and settled the federal audit for calendar years 2013 and 2014. For these years, Kodak originally recorded a federal unrecognized tax position totaling $41 million, which was fully offset by tax attributes. This settlement resulted in an increase in net deferred tax assets and was fully offset by a corresponding increase in Kodak’s U.S. valuation allowance, resulting in no net tax benefit.

Components of the net periodic benefit cost for all major U.S. and non-U.S. defined benefit plans are as follows:

	Three Months Ended													Nine Months Ended												Three Months Ended												Six Months Ended
	September 30,													September 30,												June 30,												June 30,
	2021							2020						2021						2020						2022						2021						2022						2021
(in millions)	U.S.				Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.			U.S.			Non-U.S.
Major defined benefit plans:
Service cost	$	3			$	1		$	2		$	1		$	8		$	3		$	8		$	3		$	3		$	1		$	2		$	1		$	6		$	2		$	5		$	2
Interest cost		12		��		2			21			2			36			4			64			6			17			2			12			1			32			4			24			2
Expected return on plan assets		(42	)			(4	)		(48	)		(5	)		(126	)		(11	)		(146	)		(14	)		(44	)		(3	)		(42	)		(4	)		(88	)		(7	)		(84	)		(7	)
Amortization of:
Prior service credit		(2	)			—			(2	)		—			(5	)		—			(5	)		—			(1	)		—			(1	)		—			(3	)		—			(3	)		—
Actuarial loss		7				2			4			2			22			6			11			5			—			2			8			2			—			5			15			4
Net pension (income) expense before special termination benefits		(22	)			1			(23	)		—			(65	)		2			(68	)		—
Special termination benefits		—				—			1			—			—			—			2			—
Net pension (income) expense from major plans		(22	)			1			(22	)		—			(65	)		2			(66	)		—			(25	)		2			(21	)		—			(53	)		4			(43	)		1
Other plans		—				—			—			—			—			—			—			1
Total net pension (income) expense	$	(22	)		$	1		$	(22	)	$	—		$	(65	)	$	2		$	(66	)	$	1		$	(25	)	$	2		$	(21	)	$	—		$	(53	)	$	4		$	(43	)	$	1

The ~~special termination benefits were incurred as~~Kodak Retirement Income Plan (“KRIP”) was remeasured on May 31, 2022 due to a plan amendment. The plan amendment increased the employees’ crediting rates from 9% or 10% of pay based on employee classification to 12% or 13% of pay, retroactive to January 1, 2022. The plan amendment also provided a one-time service credit to eligible employees’ cash balance accounts.

As a result of ~~Kodak’s restructuring actions and have been included in Restructuring costs and other~~the remeasurement, KRIP’s projected benefit obligation decreased $345 million primarily driven by an increase in the ~~Consolidated Statement~~discount rate ($376 million) partially offset by the impacts from the plan amendments ($28 million) and changes in other demographic assumptions ($3 million). The discount rate assumption used in the May 31, 2022 remeasurement was 4.16% compared to 2.54% used in the December 31, 2021 remeasurement. The remeasurement decreased the fair value of ~~Operations for that period.~~KRIP’s plan assets by $236 million. The expected long-term rate of return on plan assets assumption used in the May 31, 2022 remeasurement was unchanged from the rate used in the previous year-end remeasurement (5.20%). The net impact of the remeasurement increased the U.S. Plan’s funded status by $109 million.

Basic earnings per share computations are based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share computations include any dilutive effect of potential common shares. In periods with a net loss available to common shareholders, diluted earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per share.

A reconciliation of the amounts used to calculate basic and diluted earnings per share for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 follows:

Three Months Ended

Nine Months Ended

September 30,

September 30,

(in millions)

2021

2020

2021

2020

Net income (loss)

$
8

$
(445
)

$
30

$
(561
)
Less: Series B preferred stock cash and deemed
   dividends

(1
)

—

(3
)

—

Less: Series C preferred stock in-kind and deemed
   dividends

(2
)

—

(4
)

—

Less: Series A preferred stock cash and deemed
   dividends

—

(5
)

(3
)

(15
)
Plus: Expiration of Series A preferred stock
   embedded derivative

—

—

11

—

Net income (loss) available to common shareholders
   - basic and diluted

$
5

$
(450
)

$
31

$
(576
)

	Three Months Ended						Six Months Ended
	June 30,						June 30,
(in millions)	2022			2021			2022			2021
Net income	$	20		$	16		$	17		$	22
Less: Series B preferred stock cash and deemed dividends		(1	)		(1	)		(2	)		(2	)
Less: Series C preferred stock in-kind and deemed dividends		(1	)		(2	)		(3	)		(2	)
Less: Series A preferred stock cash and deemed dividends		—			—			—			(3	)
Plus: Expiration of Series A preferred stock embedded derivative		—			—			—			11
Less: Earnings attributable to Series C preferred shareholders		(2	)		—			(2	)		—
Net income available to common shareholders - basic	$	16		$	13		$	10		$	26

Effect of dilutive securities:
Add back: Series B preferred stock cash and deemed dividends	$	1		$	1		$	—		$	2
Add back: Series C preferred stock in-kind and deemed dividends		—			2			—			2
Net income available to common shareholders - diluted	$	17		$	16		$	10		$	30

The computation of diluted earnings per share for the three and ~~nine~~six months ended ~~September~~June 30, 2022 excluded the impact of (1) the assumed conversion of $25 million of Convertible Notes issued in 2021, (2) the assumed conversion of 1.1 million shares of Series C Preferred Stock and (3) the assumed exercise of 3.6 million outstanding employee stock options in each period because the effects would have been anti-dilutive.

The computation of diluted earnings per share for the six months ended June 30, 2022 excluded the impact of the assumed conversion of 1.0 million shares of Series B Preferred Stock and the assumed vesting of 0.2 million unvested restricted stock units because the effects would have been anti-dilutive.

The computation of diluted earnings per share for the three and six months ended June 30, 2021 excluded the impact of (1) the assumed conversion of $25 million of Convertible Notes issued in 2021, (2) the assumed ~~conversion of 1.0 million shares of Series B Preferred Stock, (3) the assumed conversion of 1.0 million shares of Series C Preferred stock, (4) the assumed~~ exercise of ~~3.1~~3.2 million outstanding employee stock options in both periods and ~~(5)~~(3) the assumed vesting of ~~0.0 million and~~ 0.3 million unvested restricted stock units ~~for the three and nine months ended September 30, 2021, respectively,~~in both periods, because the effects would have been anti-dilutive.

As a result of the net loss available to common shareholders for the three and nine months ended September 30, 2020, Kodak calculated diluted earnings per share using weighted-average basic shares outstanding. If Kodak reported income available to common shareholders for the three and nine months ended September 30, 2020 the calculation of diluted earnings per share would have included the assumed vesting of 0.6 million and 0.5 million unvested restricted stock units, respectively. The calculation of diluted earnings per share for the three months ended September 30, 2020 would have also included the assumed conversion of 1.2 million outstanding employee stock options.

The computation of diluted earnings per share for the three and nine months ended September 30, 2020 also excluded the impact of (1) the assumed conversion of 2.0 million shares of Series A Preferred Stock and (2) the assumed exercise of 3.1 million and 3.6 million outstanding employee stock options, respectively.

On February 26, 2021 James V. Continenza, Executive Chairman and Chief Executive Officer of Kodak, and the Company entered into an Executive Chairman and CEO Agreement (the “New Employment Agreement”). The New Employment Agreement is effective for a three-year period beginning on February 26, 2021. Pursuant to the New Employment Agreement, Mr. Continenza will not have the right to exercise any stock options granted to him in February 2019 or July 2020 to the extent that, after giving effect to the issuance of the Company’s common stock resulting from such exercise, Mr. Continenza (together with his affiliates and any person acting as a group), would beneficially own more than 4.99% of the then issued and outstanding shares of Common Stock (the “Beneficial Ownership Limitation”). The Beneficial Ownership Limitation shall cease and be of no further force and effect upon a Change of Control (as such term is defined in the Company’s Amended and Restated 2013 Omnibus Incentive Plan). The restrictions on the exercisability of previous stock option awards are a modification of the original awards. As the February 2019 and July 2020 stock options were fully vested prior to the modification date and there was 0 incremental value provided in the modification, 0 additional compensation expense was recognized. Also pursuant to the New Employment Agreement, Mr. Continenza was granted 200,000 fully vested restricted stock units. The Company recognized $2 million of stock-based compensation expense associated with the grant of restricted stock units.

The Company has 560 million shares of authorized stock, consisting of: (i) 500 million shares of common stock, par value $0.01 per share and (ii) 60 million shares of preferred stock, no par value, issuable in one or more series.

As of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, there were ~~78.6~~79.0 million and ~~77.2~~78.7 million shares of common stock outstanding, respectively. In the three months ended March 31, 2021 the Company issued 1.0 million shares of common stock pursuant to the Securities Purchase Agreement. Refer to Note 5, “Debt and Finance Leases” for information on the Securities Purchase Agreement.

Preferred stock issued and outstanding as of ~~September~~June 30, 2022 and December 31, 2021 consisted of 1.0 million shares of Series B Preferred Stock and ~~1.0~~1.1 million shares of Series C Preferred Stock. Preferred stock issued and outstanding as of December 31, 2020 consisted of 2.0 million shares of Series A Preferred Stock. Refer to Note 6, “Redeemable, Convertible Preferred Stock” for information on the changes in preferred stock.

Treasury stock consisted of approximately 0.8 million shares ~~and 0.7 million shares~~ as of ~~September~~both June 30, ~~2021~~2022 and December 31, ~~2020, respectively.~~2021.

The changes in Other comprehensive income (loss), by component, were as follows:

	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	September 30,						September 30,						June 30,						June 30,
(in millions)	2021			2020			2021			2020			2022			2021			2022			2021
Currency translation adjustments	$	—		$	(1	)	$	3		$	(17	)	$	(10	)	$	4		$	(5	)	$	3
Pension and other postretirement benefit plan changes
Newly established net actuarial (loss) gain		—			—			(1	)		6
Newly established net gain (loss)														109			—			109			(1	)
Tax Provision		—			—			—			—			—			—			—			—
Newly established net actuarial (loss) gain, net of tax		—			—			(1	)		6
Newly established net gain (loss), net of tax														109			—			109			(1	)
Reclassification adjustments:
Amortization of prior service credit ⁽¹⁾		(2	)		(2	)		(6	)		(6	)		(1	)		(2	)		(3	)		(4	)
Amortization of actuarial losses ⁽¹⁾		9			5			28			15			2			10			4			19
Recognition of losses due to curtailments and settlements		—			—			—			1
Total reclassification adjustments		7			3			22			10			1			8			1			15
Tax provision		—			—			—			(1	)		—			—			—			—
Reclassification adjustments, net of tax		7			3			22			9			1			8			1			15
Pension and other postretirement benefit plan changes, net of tax		7			3			21			15			110			8			110			14
Other comprehensive income (loss)	$	7		$	2		$	24		$	(2	)
Other comprehensive income													$	100		$	12		$	105		$	17

Kodak has four reportable segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals and Brand. A description of Kodak’s reportable segments follows.

Traditional Printing: The Traditional Printing segment is comprised of Prepress Solutions.

Digital Printing: The Digital Printing segment is comprised of four lines of business: the Electrophotographic Printing Solutions business, the ~~Prosper~~PROSPER business, the ~~Versamark~~VERSAMARK business and the Kodak Software business.

Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of ~~four~~three lines of business: Industrial Film and Chemicals, Motion Picture and Advanced Materials and Functional ~~Printing and Kodak Services for Business (“KSB”). KSB was sold to Swiss Post Solutions in December 2020.~~Printing.

All Other: All Other is comprised of the operations of the Eastman Business Park, a more than 1,200-acre technology center and industrial complex.

Segment Operational EBITDA and Consolidated ~~Income (Loss)~~Earnings from Operations Before Income Taxes

	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	September 30,						September 30,						June 30,						June 30,
(in millions)	2021			2020			2021			2020			2022			2021			2022			2021
Traditional Printing	$	5		$	5		$	16		$	7		$	10		$	6		$	8		$	11
Digital Printing		(2	)		(3	)		(2	)		(8	)		(4	)		—			(9	)		—
Advanced Materials and Chemicals		—			(6	)		(3	)		(22	)		1			1			(2	)		(3	)
Brand		3			3			8			7			4			3			7			5
Total of reportable segments		6			(1	)		19			(16	)		11			10			4			13
All Other		—			—			1			—
All other														1			1			1			1
Depreciation and amortization		(7	)		(9	)		(23	)		(29	)		(7	)		(8	)		(14	)		(16	)
Restructuring costs and other		—			(1	)		(1	)		(9	)		—			—			—			(1	)
Stock based compensation		(2	)		(17	)		(6	)		(18	)		(1	)		(1	)		(3	)		(4	)
Consulting and other costs ⁽¹⁾		(4	)		(4	)		(13	)		(5	)		(3	)		(4	)		(5	)		(9	)
Idle costs ⁽²⁾		(1	)		(1	)		(2	)		(2	)		—			—			(1	)		(1	)
Other operating (expense) income, net, excluding income from transition services agreement ⁽³⁾		(1	)		—			6			6
Other operating income, net⁽³⁾														—			6			—			7
Interest expense ⁽⁴⁾⁽³⁾		(9	)		(3	)		(23	)		(11	)		(10	)		(10	)		(19	)		(14	)
Pension income excluding service cost component ⁽⁴⁾⁽³⁾		25			26			76			79			27			26			57			51
Loss on early extinguishment of debt⁽⁴⁾		—			(2	)		-			(2	)
Other income (charges) net ⁽⁴⁾		2			(432	)		1			(387	)
Consolidated income (loss) from operations before income taxes	$	9		$	(444	)	$	35		$	(394	)
Other income (charges), net ⁽³⁾														1			(1	)		(2	)		(1	)
Consolidated earnings from operations before income taxes													$	19		$	19		$	18		$	26

Kodak decreased workers’ compensation reserves by approximately $1$4 million and $4$8 million in the three and ~~nine~~six months ended ~~September~~June 30, ~~2021, respectively,~~2022, driven by changes in discount rates. The decrease in reserves in the three ~~and nine~~ months ended ~~September~~June 30, ~~2021~~2022 impacted gross profit by approximately $1$2 million and ~~$3 million, respectively.~~ Selling, general and administrative expenses (“SG&A”) ~~were not impacted~~by approximately $2 million. The decrease in reserves in the ~~three~~six months ended ~~September~~June 30, ~~2021 and were~~2022 impacted gross profit by approximately $1$5 million ~~in the nine months ended September 30, 2021.~~and Selling, general and administrative expenses by approximately $3 million.

Kodak ~~increased~~decreased workers’ compensation reserves by approximately $9$3 million in the ~~third~~second quarter of ~~2020~~2021, driven by changes in discount rates. The ~~increase~~decrease in reserves in the ~~third~~second quarter of ~~2020~~2021 impacted gross profit by approximately ~~$6 million, SG&A by approximately~~ $2 million and ~~R&D~~Selling, general and administrative expenses by approximately $1 million.

Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”).

As demonstrated in the above table, Operational EBITDA represents the earnings ~~(loss)~~ from operations excluding the provision for income taxes; non-service cost components of pension and other postemployment benefits (“OPEB”) income; ~~loss on early extinguishment of debt,~~ depreciation and amortization expense; restructuring costs; stock-based compensation expense; consulting and other costs; idle costs; other operating ~~(expense)~~ income, net (unless otherwise indicated); interest expense and other income (charges), net.

Kodak’s segments are measured using Operational EBITDA both before and after allocation of corporate SG&A. The segment earnings measure reported is after allocation of corporate SG&A as this most closely aligns with U.S. GAAP. Research and Development activities not directly relatedto the other segments are reported within the Advanced Materials and Chemicals segment.

Kodak, as a result of its global operating and financing activities, is exposed to changes in foreign currency exchange rates and interest rates, which may adversely affect its results of operations and financial position. Kodak manages such exposures, in part, with derivative financial instruments. Foreign currency forward contracts are used to mitigate currency risk related to foreign currency denominated assets and liabilities. Kodak’s exposure to changes in interest rates results from its investing and borrowing activities used to meet its liquidity needs. Kodak does not utilize financial instruments for trading or other speculative purposes.

Kodak’s foreign currency forward contracts are not designated as hedges and are marked to market through net income ~~(loss)~~ at the same time that the exposed assets and liabilities are remeasured through net income ~~(loss)~~ (both in Other (income) charges, net in the Consolidated Statement of Operations). The notional amount of such contracts open at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was approximately ~~$317~~$294 million and ~~$361~~$322 million, respectively. The majority of the contracts of this type held by Kodak as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 are denominated in euros, Chinese renminbi and Japanese yen.

The net effect of foreign currency forward contracts in the results of operations is shown in the following table:

Kodak had 0 derivatives designated as hedging instruments for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020.~~2021.

In the event of a default under the Company’s Credit Agreements, or a default under any derivative contract or similar obligation of Kodak, subject to certain minimum thresholds, the derivative counterparties would have the right, although not the obligation, to require immediate settlement of some or all open derivative contracts at their then-current fair value, but with liability positions netted against asset positions with the same counterparty.

The Company concluded that the 2021 Convertible Notes are considered more akin to a debt-type instrument and that the economic characteristics and risks of certain of the embedded conversion features are not considered clearly and closely related to the Convertible Notes. The embedded conversion features not considered clearly and closely related are the conversion at the option of the holder (“Optional Conversion”), the mandatory conversion by Kodak (“Mandatory Conversion”) and the conversion in the event of a fundamental transaction by the holder at the then applicable conversion rate (“Fundamental Change”). Accordingly, these embedded conversion features were bifurcated from the Convertible Notes and separately accounted for on a combined basis as a single derivative asset or liability. The derivative was in a liability position at ~~September~~June 30, 2022 and December 31, 2021 and was reported in Other long-term liabilities in the Consolidated Statement of Financial Position. The derivative is being accounted for at fair value with changes in fair value included in Other (income) charges, net in the Consolidated Statement of Operations.

~~As discussed in Note 6, “Redeemable, Convertible, Preferred Stock”, the~~The Company concluded that the Series B Preferred Stock and the Series C Preferred Stock are considered more akin to a debt-type instrument and that the economic characteristics and risks of the conversion in the event of a Fundamental Change is not considered clearly and closely related to the Series B and Series C Preferred Stock. Accordingly, this embedded conversion feature was bifurcated from both the Series B and Series C Preferred Stock and both are separately accounted for as a single derivative asset or liability.

Both derivatives were in a liability position at ~~September~~June 30, 2022 and December 31, 2021 and were reported in Other long-term liabilities in the Consolidated Statement of Financial Position. The derivatives are ~~being accounted for at fair value with changes in fair value included in Other (income) charges, net in the Consolidated Statement of Operations.~~

As discussed in Note 6, “Redeemable, Convertible, Preferred Stock”, the Company concluded that the Series A Preferred Stock was considered more akin to a debt-type instrument and that the economic characteristics and risks of the embedded conversion features, except where the conversion price was increased to the liquidation preference, were not considered clearly and closely related to the Series A Preferred Stock. The embedded conversion features not considered clearly and closely related are the conversion at the option of the holder (“Optional Conversion”); the ability of Kodak to automatically convert the stock after the second anniversary of issuance (“Mandatory Conversion”) and the conversion in the event of a fundamental change or reorganization (“Fundamental Change or Reorganization Conversion”). Accordingly, these embedded conversion features were bifurcated from the Series A Preferred Stock and separately accounted for on a combined basis as a single derivative asset or liability. The embedded conversion features were revalued as of February 26, 2021 when the Company repurchased 1 million of the Series A Preferred Stock and exchanged the remaining 1 million shares of Series A Preferred Stock for Series B Preferred Stock. The revaluation as of February 26, 2021 resulted in the recognition of $2 million of net expense which was included in Other (income) charges, net in the Consolidated Statement of Operations. With the repurchase and exchange of the shares of the Series A Preferred Stock the embedded conversion features derivative liability expired. The derivative was in a liability position at December 31, 2020 and was reported in Other current liabilities in the Consolidated Statement of Financial Position. The derivative was being accounted for at fair value with changes in fair value included in Other (income) charges, net in the Consolidated Statement of Operations.

Fair values of Kodak’s foreign currency forward contracts are determined using observable inputs (Level 2 fair value measurements) and are based on the present value of expected future cash flows (an income approach valuation technique) considering the risks involved and using discount rates appropriate for the duration of the contracts. The gross fair value of foreign currency forward contracts in an asset position are reported in Other current assets and the gross fair value of foreign currency forward contracts in a liability position are reported in Other current liabilities in the Consolidated Statement of Financial Position. The gross fair value of forward contracts in an asset position as of both ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was $1$0 million. The gross fair value of foreign currency forward contracts in a liability position as of ~~both September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 was $1 million and $0 ~~million.~~million, respectively.

Transfers between levels of the fair value hierarchy are recognized based on the actual date of the event or change in circumstances that caused the transfer. There were no transfers between levels of the fair value hierarchy during the three and ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

The fair value of the embedded conversion features derivatives was calculated using unobservable inputs (Level 3 fair measurements). The value of the embedded derivatives associated with the Convertible Notes and Series ~~A, Series~~ B and Series C Preferred Stock were calculated using a binomial lattice model.

The following tables present the key inputs in the determination of fair value for the embedded conversion features:

The Fundamental Change values at issuance were calculated as the difference between the total value of the Convertible Notes, Series B or Series C Preferred Stock, as applicable, and the sum of the net present value of the cash flows if the Convertible Notes are repaid at their maturity date or Series B and Series C Preferred Stock are redeemed on their redemption date and the values of the other embedded derivatives. The Fundamental Change values reduce the value of the embedded conversion features derivative liability. Other than events that alter the likelihood of a fundamental change or reorganization event, the value of the Fundamental Change reflects the value as of the issuance date, amortized for the passage of time.

The fair values of long-term debt (Level 2 fair value measurements) are determined by reference to quoted market prices of similar instruments, if available, or by pricing models based on the value of related cash flows discounted at current market interest rates. The fair values of long-term borrowings were ~~$276~~$272 million and ~~$17~~$269 million at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively.

The carrying values of cash and cash equivalents, restricted cash and the current portion of long-term debt approximate their fair values at both ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020.~~2021.

On July 13, 2022 Kodak invested $25 million of the proceeds received from the Delayed Draw Term Loans to acquire a minority preferred equity interest in Wildcat Discovery Technologies, Inc. (“Wildcat”), a private technology company that uses proprietary methods to research and develop new battery materials. Kodak has also entered into an agreement to provide coating and engineering services in collaboration with Wildcat to develop and scale film coating technologies.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This report on Form 10-Q includes “forward–looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995.

Forward–looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. When used in this document, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” “strategy,” “continues,” “goals,” ~~“targets,”~~“targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar words and expressions, as well as statements that do not relate strictly to historical or current facts, are intended to identify forward–looking statements. All forward–looking statements, including management’s examination of historical operating trends and data, are based upon Kodak’s current expectations and ~~various~~ assumptions. ~~Future events~~Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from historical results or ~~results may differ from~~ those ~~anticipated or~~ expressed in ~~the~~or implied by such forward-looking statements. Important factors that could cause actual events or results to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in the Company’s Annual Report on Form 10–K for the year ended December 31, ~~2020~~2021 under the headings “Business,” “Risk Factors,” “Legal Proceedings,” and/or “Management’s Discussion and Analysis of Financial Condition and Results of Operations–Liquidity and Capital Resources,” in the corresponding sections of this report on Form 10-Q andthe Company’s quarterly ~~reports~~report on Form 10-Q for the ~~quarters~~quarter ended March 31, ~~2021 and June 30, 2021,~~2022, and in other filings the Company makes with the SEC from time to time, as well as the following:

~~There may be~~Future events and other factors ~~that~~ may cause Kodak’s actual results to differ materially from the forward–looking statements. All forward–looking statements attributable to Kodak or persons acting on its behalf apply only as of the date of this report on Form 10-Q and are expressly qualified in their entirety by the cautionary statements included or referenced in this document.

Kodak undertakes no obligation to update or revise forward–looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events, except as required by law.

Kodak is a global ~~technology company~~manufacturer focused on commercial print and advanced materials and chemicals. Kodak provides industry-leading hardware, software, consumables and services primarily to customers in commercial print, packaging, publishing, manufacturing and entertainment. With 31,000 patents earned over 130 years of R&D, Kodak believes in the power of technology and science to enhance what the world sees and creates. Kodak’s innovative, award-winning products, combined with its customer-first approach, allows Kodak to attract customers worldwide. Kodak is committed to environmental stewardship, ~~and ongoing~~including industry leadership in developing sustainable ~~solutions. Kodak’s broad portfolio of superior products, responsive support and world-class research and development (“R&D”) make Kodak~~ solutions ~~a smart investment~~ for ~~customers looking to improve their profitability and drive growth.~~print.

~~Revenue increased $35~~Consolidated revenues in the three and six months ended June 30, 2022 were $321 million ~~(14%)~~ and ~~$111~~$611 million, ~~(15%)~~respectively, improvements of $30 million and $55 million when compared to the three and six months ended June 30, 2021, respectively (10% improvement in each period). Currency impacted revenue unfavorably in the three and six months ended June 30, 2022 compared to the three and six months ended June 30, 2021 ($19 million and $29 million, respectively).

Traditional Printing’s revenues, which accounted for 60% of Kodak’s total revenues for both the three and six months ended June 30, 2022, improved by $25 million and $49 million compared to the prior year quarter and year-to-date periods, respectively (15% improvement in each period). Volume for SONORA Process Free Plates improved by 8% and 15%, respectively, compared to the same periods in 2021. Digital Printing revenues declined $4 million (6%) and $12 million (10%) in the three and six months ended June 30, 2022, respectively, while Advanced Materials and Chemicals revenue improved $7 million (13%) and $15 million (15%), respectively.

The ongoing global impacts associated with the COVID‐19 pandemic, the war in Ukraine and other global events continue to impact Kodak’s operations. Kodak is experiencing supply chain disruptions, shortages in materials and labor, and increased labor, material and distribution costs. Kodak has implemented numerous measures to mitigate these challenges, including increasing safety stock on certain materials, increasing lead‐times, providing suppliers with longer forecasts of future demand, certifying additional sources or substitute materials where possible and implementing pricing actions. While Kodak has been able to meet current demand and has implemented numerous measures to mitigate these challenges, the ~~favorable~~full impact of ~~currency ($2 million~~the COVID‐19 pandemic, the war in Ukraine and ~~$21 million)~~other global events on Kodak’s operations and financial performance remains uncertain and will depend on several factors such as the duration of supply chain disruptions, the ability to secure raw materials and components, the ability to offset higher labor, material and distribution costs through pricing actions and the duration of the COVID‐19 pandemic, including vaccination coverage, infection rates, as well as local government restrictions. Kodak continues to work closely with government and health officials in the ~~current year~~jurisdictions where it operates to protect employees worldwide, with particular measures in place for those working in plants and distribution facilities. Kodak closed its manufacturing facility located in Shanghai, China in April 2022 in response to a mandatory government lockdown. The mandatory government lockdown ended on June 1, 2022 and Kodak’s Shanghai, China manufacturing facility has resumed operations. The temporary closure did not have a material impact on Kodak’s financial statements. None of Kodak’s other manufacturing facilities have been ordered to close by governmental authorities.

Kodak continues to monitor the rapidly evolving events surrounding the war in Ukraine and the various sanctions imposed in response to the war. Kodak is in compliance with all sanctions. Kodak is experiencing worldwide supply constraints for aluminum and electronic components, and increased energy and transportation costs due in part to the war in Ukraine.

The extent to which the military conflict in Ukraine will impact the global economy and Kodak’s business and operations remains uncertain. Kodak may continue to face further supply chain disruptions and increased costs.

The war in Ukraine and the international response have disrupted Kodak’s ability to operate its Russian subsidiary in the ordinary course, affecting its ability to pay vendors and employees, receive amounts owed from customers in Russia and deliver product. The direct operations of Kodak’s Russian subsidiary are not material to the Company’s financial statements (less than 1% of total consolidated revenues for 2021), and there were no material impacts to the consolidated results as of and for the quarter and year-to-date periods ~~respectively.~~ended June 30, 2022. Kodak is in the process of an orderly winding down of its Russian subsidiary and direct Russian operations.

Both the Traditional Printing and Digital Printing segments have been impacted by supply chain disruptions, travel restrictions, higher raw material costs and increased labor costs. To mitigate the impact of higher aluminum, energy and packaging costs, the Traditional Printing segment implemented certain pricing actions including surcharges on purchases of plates largely beginning in the latter part of the second quarter of 2021 that continue to be periodically reviewed and adjusted accordingly. Both segments have implemented numerous measures to mitigate the supply chain disruptions while meeting current demand, but Kodak expects the ability to continue to secure raw materials and components, and the ability to offset higher raw material costs through surcharges for the Traditional Printing segment, will remain a challenge throughout 2022.

The Advanced Materials and Chemicals segment has experienced supply chain disruptions and shortages associated with raw materials as well as labor shortages in certain manufacturing areas. The segment has implemented numerous measures to mitigate these challenges while meeting current demand, however, the duration and extent of supply chain disruptions and labor shortages remain unclear.

The film industry and segments within the print industry face competition from digital substitution. Kodak’s strategy is to:

A discussion of opportunities and challenges related to Kodak’s strategy follows:

~~Many of the segment’s customers around the globe continued to operate during the COVID-19 pandemic but at decreased volumes.~~ The Traditional Printing segment was impacted by supply chain disruptions and travel restrictions. Manufacturing volumes were reduced, primarily in 2020, in response to the decline in customer demand for the segment’s products. The segment saw some recovery of volumes starting in the later part of 2020 and continued improvement in customer demand in the first nine months of 2021. However, certain markets in the printing industry are expected to take longer to recover to pre-pandemic levels which makes ~~the duration and extent of demand declines, the ability to offset~~ ~~increased labor, commodity and distribution costs through surcharges~~ ~~and the ability to continue to secure raw materials and components uncertain.~~

~~Many~~In addition, Kodak officially launched the KODAK PROSPER ULTRA 520 Digital Press utilizing Kodak’s ULTRASTREAM inkjet technology, which offers offset print quality in a smaller footprint. The Electrophotographic Printing Solutions business launched a new digital press at the end of the ~~Digital Printing segment customers around~~second quarter of 2022, the ~~globe continued to operate during~~KODAK ASCEND, aimed at the ~~COVID-19 pandemic but at decreased volumes.~~ ~~The Digital Printing segment was impacted by supply chain disruptions~~growing retail, point of purchase and travel restrictions and manufacturing volumes were reduced, primarily in 2020, in response to the decline in customer demand for the segment’s products. The segment has seen some recovery of volumes starting in the later part of 2020 and continued improvement in customer demand in the first nine months of 2021; however, certain markets in the printing industry are expected to take longer to recover to pre-pandemic levels which makes ~~the duration and extent of demand declines uncertain.~~

Advanced Materials and Chemicals experienced adverse impacts from the COVID-19 pandemic in 2020, most notably in Motion Picture where the industry was heavily impacted and productions in affected regions were suspended. Each of the segment’s product lines was impacted by lowered demand and travel restrictions. The segment has seen a recovery of customer demand starting in the later part of 2020 for Motion Picture film and other Advanced Materials and Chemicals product lines, which continued in the first nine months of 2021 with volume improvements compared with the prior year quarter and year-to-date periods. Advanced Materials and Chemicals has experienced supply chain disruptions and shortages associated with raw materials as well as labor shortages in certain manufacturing areas.

~~The segment has implemented numerous measures to mitigate these challenges while meeting current demand, however,~~ ~~the duration and extent of supply chain disruptions and labor shortages remain unclear.~~small packaging markets.

	Three Months Ended June 30,															Six Months Ended June 30,
(in millions)	2022			% of Sales			2021			% of Sales			$ Change			2022			% of Sales			2021			% of Sales			$ Change
Revenues	$	321					$	291					$	30		$	611					$	556					$	55
Cost of revenues		270						243						27			527						468						59
Gross profit		51			16	%		48			16	%		3			84			14	%		88			16	%		(4	)
Selling, general and administrative expenses		41			13	%		42			14	%		(1	)		84			14	%		88			16	%		(4	)
Research and development costs		9			3	%		8			3	%		1			18			3	%		16			3	%		2
Restructuring costs and other		—			0	%		0			0	%		0			-			0	%		1			0	%		(1	)
Other operating income, net		—			0	%		(6	)		(2	)%		6			-			0	%		(7	)		(1	)%		7
Earnings (loss) from operations before interest expense, pension income excluding service cost cost component, other (income) charges, net and income taxes		1			0	%		4			1	%		(3	)		(18	)		(3	)%		(10	)		(2	)%		(8	)
Interest expense		10			3	%		10			3	%		—			19			3	%		14			3	%		5
Pension income excluding service cost component		(27	)		(8	)%		(26	)		(9	)%		(1	)		(57	)		(9	)%		(51	)		(9	)%		(6	)
Other (income) charges, net		(1	)		(0	)%		1			0	%		(2	)		2			0	%		1			0	%		1
Earnings from operations before income taxes		19			6	%		19			7	%		—			18			3	%		26			5	%		(8	)
(Benefit) provision for income taxes		(1	)		(0	)%		3			1	%		(4	)		1			0	%		4			1	%		(3	)
Net income	$	20			6	%	$	16			5	%	$	4		$	17			3	%	$	22			4	%	$	(5	)

For the three months ended June 30, 2022 revenues improved $30 million compared with the same period in 2021, driven by improved pricing within Traditional Printing ($50 million), improved pricing and product mix and increased volume within Advanced Materials and Chemicals ($5 million and $3 million, respectively) and improved pricing in Digital Printing ($2 million). Partially offsetting these favorable impacts was lower volume in Traditional Printing and Digital Printing ($8 million and $3 million, respectively) and unfavorable foreign currency ($19 million). See segment discussions for additional details.

For the six months ended June 30, 2022 revenues improved $55 million compared with the same period in 2021, primarily due to improved pricing within Traditional Printing ($72 million), improved pricing and product mix and increased volume within Advanced Materials and Chemicals ($10 million and $5 million, respectively) and improved volume in Brand ($2 million). Partially offsetting these favorable impacts was lower volume in Digital Printing ($9 million) and unfavorable foreign currency ($29 million). See segment discussions for additional details.

Gross profit for the three months ended June 30, 2022 improved approximately $3 million compared with the same period in 2021, primarily due to improved pricing within Traditional Printing ($50 million) and improved pricing and product mix in Advanced Materials and Chemicals ($4 million). Partially offsetting these favorable impacts was higher aluminum costs in Traditional Printing ($29 million), higher manufacturing costs in Traditional Printing ($14 million) and Advanced Materials and Chemicals ($4 million) and unfavorable foreign currency ($4 million). See segment discussions for additional details.

Gross profit for the six months ended June 30, 2022 declined approximately $4 million compared with the same period in 2021, primarily due to higher aluminum costs in Traditional Printing ($44 million), higher manufacturing costs in Traditional Printing ($28 million), Digital Printing ($6 million) and Advanced Materials and Chemicals ($7 million) and unfavorable foreign currency ($6 million). Partially offsetting these unfavorable impacts was improved pricing in Traditional Printing ($72 million), improved pricing and product mix and higher volume in Advanced Materials and Chemicals (each $4 million), higher margins in Digital Printing and improved volume in Brand (each $2 million) and a decrease in workers’ compensation reserves ($2 million). See segment discussions for additional details.

Consolidated SG&A decreased $1 million and $4 million in the three and six months ended June 30, 2022, respectively. The decrease in the three months ending June 30, 2022 was primarily due to lower consulting and other costs primarily associated with investigations and litigation and favorable foreign currency (each $1 million) compared to the prior year period, partially offset by an increase in selling and administrative costs ($1 million). The decrease in the six months ending June 30, 2022 was primarily due to lower consulting and other costs primarily associated with investigations and litigation ($4 million), a decrease in workers’ compensation reserves ($2 million), lower equity based compensation ($1 million) and favorable foreign currency ($2 million) partially offset by an increase in selling and administrative costs ($5 million).

Consolidated R&D expenses increased $1 million and $2 million in the three and six months ended June 30, 2022, respectively.

Pension income excluding service cost component increased $1 million and $6 million in the three and six months ended June 30, 2022, respectively. As a result of the remeasurement of the KRIP plan on May 31, 2022, total pension income from continuing operations before special termination benefits, curtailments and settlements is expected to be approximately $88 million in 2022, a decrease of $25 million from the previous estimate driven by an increase in the discount rate.

Kodak has four reportable segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The balance of Kodak’s operations, which do not meet the criteria of a reportable segment, are reported in All Other and primarily represent the Eastman Business Park operations. Refer to the ~~2020~~2021 Form 10-K for a description of the Company’s segments.

Segment Operational EBITDA and Consolidated ~~Income (Loss)~~Earnings from Operations Before Income Taxes

	Three Months Ended						Nine Months Ended						Three Months Ended						Six Months Ended
	September 30,						September 30,						June 30,						June 30,
(in millions)	2021			2020			2021			2020			2022			2021			2022			2021
Traditional Printing	$	5		$	5		$	16		$	7		$	10		$	6		$	8		$	11
Digital Printing		(2	)		(3	)		(2	)		(8	)		(4	)		—			(9	)		—
Advanced Materials and Chemicals		—			(6	)		(3	)		(22	)		1			1			(2	)		(3	)
Brand		3			3			8			7			4			3			7			5
All Other		—			—			1			—
All other														1			1			1			1
Depreciation and amortization		(7	)		(9	)		(23	)		(29	)		(7	)		(8	)		(14	)		(16	)
Restructuring costs and other		—			(1	)		(1	)		(9	)		—			—			—			(1	)
Stock based compensation		(2	)		(17	)		(6	)		(18	)		(1	)		(1	)		(3	)		(4	)
Consulting and other costs ⁽¹⁾		(4	)		(4	)		(13	)		(5	)		(3	)		(4	)		(5	)		(9	)
Idle costs ⁽²⁾		(1	)		(1	)		(2	)		(2	)		—			—			(1	)		(1	)
Other operating (expense) income, net, excluding income from transition services agreement (3)		(1	)		—			6			6
Other operating income, net ⁽³⁾														—			6			—			7
Interest expense ⁽⁴⁾⁽³⁾		(9	)		(3	)		(23	)		(11	)		(10	)		(10	)		(19	)		(14	)
Pension income excluding service cost component ⁽⁴⁾⁽³⁾		25			26			76			79			27			26			57			51
Loss on early extinguishment of debt (4)		—			(2	)		—			(2	)
Other income (charges) net (4)		2			(432	)		1			(387	)
Consolidated income (loss) from operations before income taxes	$	9		$	(444	)	$	35		$	(394	)
Other income (charges), net ⁽³⁾														1			(1	)		(2	)		(1	)
Consolidated earnings from operations before income taxes													$	19		$	19		$	18		$	26

Kodak decreased workers’ compensation reserves by approximately $1$4 million and $4$8 million in the three and ~~nine~~six months ended ~~September~~June 30, ~~2021, respectively,~~2022, driven by changes in discount rates. The decrease in reserves in the three ~~and nine~~ months ended ~~September~~June 30, ~~2021~~2022 impacted gross profit by approximately $1$2 million and ~~$3 million, respectively. Selling, general and administrative~~SG&A expenses ~~(“SG&A”) were not impacted~~by approximately $2 million. The decrease in reserves in the ~~three~~six months ended ~~September~~June 30, ~~2021 and were~~2022 impacted gross profit by approximately $1$5 million ~~in the nine months ended September 30, 2021.~~and SG&A expenses by approximately $3 million.

Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”). Operational EBITDA represents the earnings ~~(loss)~~ from operations excluding the provision for income taxes; non-service cost components of pension and OPEB income; ~~loss on early extinguishment of debt,~~ depreciation and amortization expense; restructuring costs; stock-based compensation expense; consulting and other costs; idle costs; other operating income, net (unless otherwise indicated); interest expense and other income (charges), net.

Kodak’s segments are measured using Operational EBITDA both before and after the allocation of corporate SG&A expenses. The segment earnings measure reported is after allocation of corporate SG&A as this most closely aligns with U.S. GAAP. Research and development activities not directly related to the other segments are reported within the Advanced Materials and Chemicals segment.

Three Months Ended September 30,

Nine Months Ended September 30,

(in millions)

2021

% of
Sales

2020

% of
Sales

$ Change

2021

% of
Sales

2020

% of
Sales

$ Change

Revenues

$
287

$
252

$
35

$
843

$
732

$
111

Cost of revenues

244

221

23

712

644

68

Gross profit

43

15
%

31

12
%

12

131

16
%

88

12
%

43

Selling, general and administrative expenses

43

15
%

56

22
%

(13
)

131

16
%

138

19
%

(7
)
Research and development costs

8

3
%

8

3
%

0

24

3
%

25

3
%

(1
)
Restructuring costs and other

—

0
%

1

0
%

(1
)

1

0
%

9

1
%

(8
)
Other operating expense (income), net

1

0
%

(1
)

(0
)%

2

(6
)

(1
)%

(11
)

(2
)%

5

Loss from operations before interest
   expense, pension income excluding
   service cost component, loss on early
   extinguishment of debt, other (income)
   charges, net and income taxes

(9
)

(3
)%

(33
)

(13
)%

24

(19
)

(2
)%

(73
)

(10
)%

54

Interest expense

9

3
%

3

1
%

6

23

3
%

11

2
%

12

Pension income excluding service cost
   component

(25
)

(9
)%

(26
)

(10
)%

1

(76
)

(9
)%

(79
)

(11
)%

3

Loss on early extinguishment of debt

-

0
%

2

1
%

(2
)

-

0
%

2

0
%

(2
)
Other (income) charges, net

(2
)

(1
)%

432

171
%

(434
)

(1
)

(0
)%

387

53
%

(388
)
Earnings (loss) from operations before
    income taxes

9

3
%

(444
)

(176
)%

453

35

4
%

(394
)

(54
)%

429

Provision for income taxes

1

0
%

1

0
%

0

5

1
%

167

23
%

(162
)
Net income (loss)

$
8

3
%

$
(445
)

(177
)%

$
453

$
30

4
%

$
(561
)

(77
)%

$
591

For the three months ended September 30, 2021 revenues improved $35 million compared with the same period in 2020, driven by increased volume within Traditional Printing ($18 million), Advanced Materials and Chemicals ($8 million) and Digital Printing ($1 million), improved pricing in Advanced Materials and Chemicals ($3 million) and Traditional Printing ($2 million) and favorable foreign currency ($2 million). See segment discussions for additional details.

For the nine months ended September 30, 2021 revenues improved $111 million compared with the same period in 2020, driven by increased volume within Traditional Printing ($49 million), Advanced Materials and Chemicals ($26 million), Digital Printing ($9 million) and Other ($3 million), improved pricing in Advanced Materials and Chemicals ($4 million) and favorable foreign currency ($21 million). The revenue improvements were offset by unfavorable pricing in Digital Printing ($2 million). See segment discussions for additional details.

Gross profit for the three months ended September 30, 2021 improved approximately $12 million compared with the same period in 2020, primarily due to increased volume within Advanced Materials and Chemicals and Traditional Printing ($3 million and $1 million, respectively), improved pricing and product mix in Advanced Materials and Chemicals and Traditional Printing (each $3 million), a decrease in workers’ compensation reserves ($7 million), improved manufacturing costs driven by more favorable cost absorption ($2 million) and lower depreciation and amortization expenses ($2 million), partially offset by volume changes in Digital Printing ($2 million) and higher aluminum costs ($7 million). See segment discussions for additional details.

Gross profit for the nine months ended September 30, 2021 improved approximately $43 million compared with the same period in 2020, primarily due to improved manufacturing costs ($24 million) driven by more favorable cost absorption from improved volume, increased volume in Advanced Materials and Chemicals ($10 million), favorable product mix in Advanced Materials and Chemicals and Traditional Printing ($4 million and $2 million, respectively), a decrease in workers’ compensation reserves ($9 million) and lower depreciation and amortization expenses ($6 million), partially offset by higher aluminum costs ($11 million) and volume declines in Digital Printing ($3 million). See segment discussions for additional details.

Consolidated SG&A decreased $13 million and $7 million in the three and nine months ended September 30, 2021, respectively. The decrease in the three months ended September 30, 2021 was driven by higher stock compensation expense recognized in the prior year quarter ($16 million) and a decrease in workers’ compensation reserves ($2 million) partially offset by increased investment in segment selling and marketing activities ($6 million) primarily due to temporary furloughs and pay cuts in the third quarter of 2020 ($7 million) that largely ended in January 2021. The $7 million decrease in the nine months ended September 30, 2021 was driven by higher stock compensation expense recognized in the prior year-to-date period ($13 million) and a decrease in workers’ compensation reserves ($3 million). Offsetting these impacts were higher consulting and other costs in 2021 ($8 million) associated with the internal and external investigations and related litigation that started in the third quarter of 2020 and increased investment in segment selling and marketing activities ($3 million) primarily due to temporary furloughs and pay cuts in 2020 ($18 million) that largely ended in January 2021. In addition, the prior year period included higher bad debt expense reflecting the increased collection risk associated with the COVID-19 pandemic ($3 million).

~~Consolidated R&D expenses remained flat for the quarter and decreased $1 million for the year, primarily due to a decrease in workers’ compensation reserves.~~

The change in Other (income) charges, net in 2020 was primarily driven by the change in the fair value of the embedded conversion features derivative liability associated with the Convertible Notes issued in 2019 at the time of their conversion due to the volatility of the Company’s stock in the third quarter of 2020. Refer to Note 12, “Other (Income) Charges, Net”.

The change in Provision for income taxes for the nine months ended September 30, 2020 was driven by the $167 million provision associated with the establishment of a valuation allowance on deferred tax assets outside the U.S. in 2020. Refer to Note 13, “Income Taxes”.

The increase in Traditional Printing revenues for the three months ended ~~September~~June 30, ~~2021~~2022 of approximately ~~$20~~$25 million reflected improved ~~volume~~pricing in Prepress Solutions consumables ($49 million) partially offset by reduced volumes in Prepress Solutions consumables and equipment ($165 million and $2$4 million, respectively) ~~as the prior year period was impacted by the COVID-19 pandemic, improved pricing in Prepress Solutions consumables ($3 million)~~ and ~~favorable~~unfavorable foreign currency ($~~1 million) partially offset by unfavorable product mix in in Prepress Solutions equipment ($1~~15 million).

The increase in Traditional Printing revenues for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 of approximately ~~$64~~$49 million reflected improved pricing and volume in Prepress Solutions consumables ~~and equipment~~ ($4572 million and $6$4 million, respectively) as the prior year period was impacted by the COVID-19 pandemic, improved pricing in in Prepress Solutions consumables ($2 million) and favorable foreign currency ($15 million). The favorable impacts were partially offset by ~~unfavorable product mix~~reduced volumes in Prepress Solutions equipment ($3 million) and ~~volume declines in Prepress Solutions service~~unfavorable foreign currency ($223 million).

Traditional Printing Operational EBITDA for the three months ended ~~September~~June 30, ~~2021 was flat compared to the prior year quarter~~2022 improved $4 million reflecting ~~volume and pricing~~price improvements ~~($2 million and $3 million, respectively)~~ in Prepress Solutions ~~consumables. improved manufacturing costs~~consumables ($349 million) ~~primarily due to more favorable cost absorption and a decrease in workers’ compensation reserves ($3 million). The improvements were~~partially offset by higher aluminum costs ($729 million), ~~higher sales~~increased manufacturing costs ($14 million) driven by increases in other costs such as utilities, transportation and ~~marketing expenses ($4 million), primarily due to temporary furloughs and pay cuts in the prior year period~~supplies and unfavorable foreign currency ($12 million).

Traditional Printing Operational EBITDA for the ~~nine~~six months ended ~~September~~June 30, ~~2021 improved $9~~2022 declined $3 million reflecting ~~improved~~higher aluminum costs ($44 million), increased manufacturing costs ($2128 million) ~~primarily due to more favorable cost absorption, volume~~driven by increases in other costs such as utilities, transportation and supplies as well as higher selling and administrative costs ($1 million) and unfavorable foreign currency ($2 million). The higher costs were partially offset by pricing improvements ~~(each $2~~($72 million) in Prepress Solutions consumables and a decrease in workers’ compensation reserves ($3 million). The favorable impacts were partially offset by higher aluminum costs ($11 million), higher sales and marketing expenses ($5 million) primarily due to temporary furloughs and pay cuts in the prior year period and unfavorable foreign currency ($3 million).consumables.

The ~~improvement~~decline in Digital Printing revenues for the three months ended ~~September~~June 30, ~~2021~~2022 of approximately $2$4 million primarily reflected volume ~~improvements and more favorable pricing in Prosper consumables and service ($2 million and $1 million, respectively), volume improvements~~declines in Electrophotographic Printing Solutions ~~consumables and service ($1 million) and favorable foreign currency ($1 million). The improvements were partially offset by volume declines in Prosper components~~equipment ($2 million) and ~~Versamark consumables and service~~unfavorable foreign currency ($13 million).

The ~~improvement~~decline in Digital Printing revenues for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 of approximately ~~$11~~$12 million primarily reflected volume ~~improvements~~declines in PROSPER equipment and improved pricing ($7 million and $2 million, respectively) in Prosper consumables and service, improved volume in Prosper systems and Electrophotographic Printing Solutions equipment ($1 million and $6 million, respectively) and favorable foreign currency ($5 million). The improvements, which were largely due to the impact of COVID-19 pandemic in the prior year period, were partially offset by volume declines and less favorable pricing in Prosper components ($54 million and $1 million, respectively), volume declines in ~~Versamark~~Electrophotographic Printing Solutions equipment and VERSAMARK consumables and service ($23 million and $1 million, respectively) and unfavorable foreign currency ($5 million) partially offset by improved pricing in PROSPER annuities and ~~less favorable pricing~~improved product mix in Electrophotographic Printing Solutions ~~equipment ($3~~(both $1 million) ~~and Electrophotographic Printing Solutions consumables and service ($1 million)~~.

Digital Printing Operational EBITDA for the three months ended ~~September~~June 30, ~~2021 improved $1~~2022 declined $4 million primarily ~~reflected a decrease in workers’ compensation reserves~~reflecting increased manufacturing costs ($31 million) and higher SG&A and R&D costs ($2 million) partially offset by ~~volume declines in Prosper components ($1 million) and the unfavorable impact of volume changes in~~higher margins on Electrophotographic Printing Solutions equipment ($1 million).

Digital Printing Operational EBITDA for the ~~nine~~six months ended ~~September~~June 30, ~~2021 improved $6~~2022 declined $9 million ~~reflected improved~~primarily reflecting increased manufacturing costs ($26 million), ~~improved volume~~higher SG&A and ~~product mix in Prosper consumables and service~~R&D costs ($3 ~~million and $1 million, respectively), lower workers’ compensation reserves ($5 million) and favorable foreign currency ($2~~ million), ~~partially offset by volume declines and unfavorable pricing in Prosper components ($3 million and $2 million, respectively) as well as~~ unfavorable pricing in Electrophotographic Printing Solutions consumables and service ($1 million) and unfavorable foreign currency ($1 million) partially offset by higher margins on Electrophotographic Printing Solutions equipment ~~($2~~and a decrease in workers’ compensation reserves (each $2 million).

Advanced Materials and Chemicals revenues for the three months ended ~~September~~June 30, ~~2021~~2022 improved ~~$11~~$7 million primarily from ~~volume~~pricing and product mix improvements and ~~higher pricing~~increased volume in Industrial Film and Chemicals ($5 million and $3$2 million, respectively) as well as volume improvements in Motion Picture ($5 million) largely due to a lessening of the impact of the COVID-19 pandemic on this industry. These improvements were partially offset by volume declines from KSB ($2 million) as the business was sold in December 2020..

Advanced Materials and Chemicals revenues for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 improved ~~$31~~$15 million primarily from volume improvements in Industrial Film and ~~higher~~Chemicals and Motion Picture ($7 million and $4 million, respectively) and improved pricing and product mix in Industrial Film and Chemicals ($~~18 million and $4 million, respectively) as well as volume improvements in Motion Picture ($14~~5 million) ~~due to the impact of COVID-19 pandemic in the prior year period as well as favorable~~partially offset by unfavorable foreign currency ($1 million). Partially offsetting these impacts were volume declines in Consumer Inkjet Solutions ($1 million) as the final build of inventory was sold in the first half of 2020. Additionally, the prior year period included revenues from KSB ($5 million) which was sold in December 2020.

Advanced Materials and Chemicals Operational EBITDA was flat for the three months ended June 30, 2022 reflecting pricing and product mix improvements in Industrial Film and Chemicals ($4 million), offset by increased manufacturing costs for Industrial Film and Chemicals ($4 million).

Advanced Materials and Chemicals Operational EBITDA improved $6$1 million for the ~~three~~six months ended ~~September~~June 30, ~~2021~~2022 reflecting ~~favorable~~improved pricing and product mix and increased volume ~~and higher prices~~ in Industrial Film and Chemicals ($24 million and $3 million, respectively), increased volume ~~improvements~~ in Motion Picture ($21 million) and a reduction in workers’ compensation reserves ($32 million),. The favorable impacts were partially offset by increased manufacturing costs for Industrial Film and Chemicals ($~~3 million).~~

Advanced Materials and Chemicals Operational EBITDA improved $19 million for the nine months ended September 30, 2021 reflecting favorable volume and higher prices in Industrial Film and Chemicals ($6 million and $4 million, respectively), volume improvements in Motion Picture ($57 million), ~~a decrease in workers’ compensation reserves~~increased SG&A costs ($51 million) and ~~favorable~~unfavorable foreign currency ($1 million).

Brand revenues and operational EBITDA improved $1 million and $2 million ~~respectively~~ in the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 compared to the prior year quarter and year-to-date ~~periods.~~period due to increased volume.

Kodak recorded ~~$0 million and~~less than $1 million of charges for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021, respectively,~~2022 in Restructuring costs and other in the Consolidated Statement of Operations.

Kodak made cash payments related to restructuring of approximately $2$1 million and $8$3 million during the three and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively.

The restructuring actions implemented in the first ~~nine~~six months of ~~2021~~2022 are expected to generate future annual cash savings of approximately ~~$4 million. These savings~~$1 million, which are expected to reduce future annual ~~Cost of revenues and~~ SG&A ~~expenses by $2 million each. Kodak began realizing a portion of these savings in the first nine months of 2021 and expects the~~expenses. The majority of the annual savings ~~to be~~were already in effect by the end of ~~2021 as these actions are completed.~~the second quarter of 2022.

Kodak ended the quarter with a cash balance of $289 million, a decrease of $73 million from December 31, 2021. On June 15, 2022, Kodak exercised its right to draw down in full an additional $50 million in aggregate principal pursuant to the Term Loan Credit Agreement and received net proceeds of $49 million. On July 13, 2022, Kodak invested $25 million of the proceeds received from the Delayed Draw Term Loans to acquire a minority preferred equity interest in Wildcat, a private technology company that uses proprietary methods to research and develop new battery materials.

The financing transactions entered into during the first quarter of 2021 and the full draw down of the Delayed Draw Term Loans in the second quarter of 2022 provided additional liquidity to the Company to fund ~~on-going~~on‐going operations and obligations, ~~and to~~ invest in growth opportunities in Kodak’s ~~core~~ businesses of print and advanced materials and chemicals ~~as well as~~and for corporate infrastructure investments expected to contribute to improvements in cash flow. Kodak’s plans to return to sustainable positive cash flow include growing revenues profitably, reducing operating expenses, continuing to simplify the organizational structure, generating cash from selling and leasing underutilized assets and implementing ways to reduce cash collateral needs. Kodak believes the expected cash provided from operating activities, together with the current levels of cash and cash equivalents, available borrowing capacity under the Amended ABL Credit Agreement and additional liquidity measures will be sufficient to meet the Company’s short‐term and long‐term cash requirements, as further described below.

Kodak’s products are sold and serviced in numerous countries across the globe with more than half of sales generated outside the U.S. Current global economic conditions remain highly volatile due to conditions associated with the on-going COVID-19 ~~pandemic. The conversion of accounts receivable to cash is improving but collection risk remains high. Certain~~pandemic, the war in Ukraine and other global events. Kodak businesses are experiencing supply chain disruptions, shortages in materials and labor, and increased labor, commodity and distribution costs. Kodak has implemented numerous measures to mitigate the economic impacts of the COVID-19 pandemic, including reducing operating costs, largely beginning in the second quarter of 2020, through the use of temporary furloughs and pay reductions, adjusting manufacturing volumes to meet changing expectations around production requirements and implementing surcharges on purchases of plates. The furloughs and pay-cuts largely ended in January 2021. While manufacturing volumes have improved since 2020 at the height of the pandemic, the economic uncertainty surrounding the COVID-19 pandemic, the war in Ukraine, the current inflationary environment and other global events represents an additional element of complexity in Kodak’s plans to return to sustainable positive cash flow. The Company cannot predict the duration and scope of the COVID-19 pandemic, the ~~severity of the virus, the emergence and spread of new variants,~~war in Ukraine, as well as other factors such as the ability to continue to secure raw materials and components, the impact of rising costs of labor, commodity and distribution costs, or how quickly and to what extent normal economic and operating conditions can resume.

Net cash used in operating activities ~~decreased $15~~increased $82 million for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 as compared with the corresponding period in ~~2020~~2021 primarily due to ~~improved earnings, decreases~~an increase in trade receivables driven by revenue growth, increased investment in inventory to strengthen the ability to supply customers, increase in cash used for accounts payable and ~~proceeds from legal settlements partially offset by~~ lower ~~reductions of accounts receivable and increased investment in inventory in 2021.~~cash earnings.

~~There was no change in net~~Net cash used in investing activities increased $4 million for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 as compared with the corresponding period in ~~2020.~~2021 due to an increase in capital expenditures.

~~Net~~The change in net cash provided by financing activities for the ~~nine~~six months ended ~~September~~June 30, ~~2021 improved $230 million~~2022 compared to ~~the~~ corresponding period in ~~2020~~2021 was primarily driven by the net proceeds of $247 million received in the prior year period from the ~~current year~~ refinancing transactions ~~and~~partially offset by net proceeds of $49 million received in the second quarter of 2022 from the Delayed Draw Term Loans as well as lower preferred stock ~~cash~~ dividend payments ~~($13 million) partially offset by proceeds received from stock option exercises ($29 million)~~ in the ~~prior~~current year period.

Available liquidity includes cash balances and the unused portion of the Amended ABL Credit Agreement. The amount of available liquidity is subject to fluctuations and includes cash balances held by various entities worldwide. At ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020~~2021 approximately ~~$263~~$203 million and ~~$99~~$250 million, respectively, of cash and cash equivalents were held within the U.S. and approximately ~~$117~~$86 million and ~~$97~~$112 million, respectively, of cash and cash equivalents were held outside the U.S.

Cash balances held outside the U.S. are generally required to support local country operations and may have high tax costs or other limitations that delay the ability to repatriate, and therefore may not be readily available for transfer to other jurisdictions. Kodak utilizes cash balances outside the U.S. to fund needs in the U.S. through the use of inter-company loans.

As of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, outstanding inter-company loans to the U.S. were ~~$413~~$390 million and ~~$449~~$418 million, respectively, which includes short-term inter-company loans from Kodak’s international finance center of ~~$115~~$91 million and ~~$150~~$119 million, respectively. In China, where approximately ~~$35~~$33 million and ~~$34~~$42 million of cash and cash equivalents was held as of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively, there are limitations related to net asset balances that may impact the ability to make cash available to other jurisdictions in the world. Under the terms of the Amended ABL Credit Agreement, the Company is permitted to invest up to $75 million in Restricted Subsidiaries that are not Loan Parties and in joint ventures or Unrestricted Subsidiaries that are not party to the Amended ABL Credit Agreement.

The Company had issued approximately ~~$42~~$46 million letters of credit under the Amended ABL Credit Agreement and $44 million letters of credit under the L/C Facility Agreement as of ~~September~~June 30, 2022 and December 31, 2021. The letters of credit under the L/C Facility Agreement are collateralized by cash collateral (L/C Cash Collateral). The L/C Cash Collateral was $45 million at ~~September~~June 30, ~~2021~~2022 which was classified as Restricted Cash. ~~The Company issued approximately $90 million letters of credit under the ABL Credit Agreement as of December 31, 2020.~~

Under the Amended ABL Credit Agreement and L/C Facility Agreement the Company is required to maintain Minimum Liquidity of at least $80 million, which is tested on the last day of each fiscal quarter. Minimum Liquidity was ~~$263~~$203 million and $250 million at ~~September~~June 30, ~~2021.~~2022 and December 31, 2021, respectively. If Minimum Liquidity falls below $80 million an Event of Default would occur and the Agent has the right to declare the obligation of each Lender to make Revolving Loans and of the Issuing Banks to issue Letters of Credit to be terminated, and declare the Revolving Loans, all interest thereon and all other amounts payable under the Amended ABL Credit Agreement to be due and payable.

If Excess Availability falls below 12.5% of lender commitments a Fixed Charge Coverage Ratio Trigger Event would occur. During any Fixed Charge Coverage Ratio Trigger Event, the Company would be required to maintain a Fixed Charge Coverage Ratio of greater than or equal to 1.0 to 1.0.

If Excess Availability falls below 12.5% of lender commitments, Kodak may, in addition to the requirement to be in compliance with the minimum Fixed Charge Coverage Ratio, become subject to cash dominion control. Since Excess Availability was greater than 12.5% of lender commitments at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, Kodak is not required to have a minimum Fixed Charge Coverage Ratio of 1.0 to 1.0. The Amended ABL Credit Agreement also removed Eligible Cash from the Borrowing Base. Therefore, amounts funded into the Eligible Cash account will no longer increase Excess Availability for purposes of compliance reporting. As of December 31, 2020, to maintain Excess Availability of greater than 12.5% of lender commitments, Kodak funded $35 million to the Eligible Cash account held with the ABL Credit Agreement Administrative Agent, which was classified as Restricted Cash in the Consolidated Statement of Financial Position.

Kodak intends to continue to maintain Excess Availability above the minimum threshold. The borrowing base is supported by Eligible Receivables, Eligible Inventory and Eligible Equipment. As noted above, since Excess Availability was greater than 12.5% of lender commitments Kodak was not required to have a minimum Fixed Charge Coverage Ratio of 1.0 to 1.0. As of June 30, 2022 Fixed Charges (as defined in the ABL Credit Agreement) exceeded EBITDA by approximately $67 million, therefore the Fixed Charges Coverage Ratio was less than 1.0 to 1.0.

The Term Loan Credit Agreement included a commitment to provide Delayed Draw Term Loans in an aggregate principal amount of $50 million on or before February 26, 2023. The Company drew down the $50 million of Delayed Draw Term Loans on June 15, 2022.

The holders of the Term Loans are entitled to quarterly cash interest payments at a rate of 8.5% per annum and holders of the Series B Preferred Stock are entitled to cumulative dividends payable quarterly in cash at a rate of 4.0% per annum. The Convertible Notes do not require any debt service until maturity on May 28, 2026 and holders of the Series C Preferred Stock are entitled to cumulative dividends payable quarterly “in-kind” in the form of additional shares of Series C Preferred Stock at a rate of 5.0% per annum. All dividends have been paid when due.

The New York State Workers’ Compensation Board (“NYSWCB”) requires security deposits related to self-insured workers’ compensation obligations. The security deposit required by NYSWCB is based on actuarial calculations of the Company’s obligations and company specific factors such as its declining workforce and reducing exposure.

The NYSWCB calculation also includes a financial contingency based on the employer’s credit rating and a calculation of unallocated loss adjustment expenses. In 2020 the NYSWCB waived both of these charges to provide employers relief while they managed the economic impacts of the COVID-19 pandemic. In 2021 the NYSWCB waived the financial contingency based on the Company’s credit rating. The waived security deposit was $17 million in 2020 and increased to $39 million in 2021. After excluding the waived amount for 2021, the increase to the security deposit required by NYSWCB is $19 million. The Company ~~has~~ agreed to post additional collateral of approximately $4 million over a five-year period, starting in 2021, to satisfy the security deposit obligation. The collateral obligation can be satisfied by issuing letters of credit or through other means. The ~~additional collateral requirement for 2021 must be funded by November 15, 2021 and the Company plans to fund it by issuing letters of credit. The~~ security deposit required by NYSWCB will be re-calculated annually. Therefore, the amount of additional collateral required may change each year.

As a result of the Company’s ~~current~~ credit ratings, during the second quarter of 2020 two surety bond holders notified the Company they required approximately $9 million of incremental collateral. The Company reduced the surety bond value by approximately $9 million in July 2020 with an equivalent increase to an existing letter of credit with the New York Workers’ Compensation ~~board.~~Board. The Company could be required to provide up to $3 million of letters of credit to the issuers of certain surety bonds in the future to fully collateralize the bonds.

~~U.S. International Development Finance Corporation Non-Binding Letter of Interest~~

On July 28, 2020 the U.S. International Development Finance Corporation (the “DFC”) announced (the “DFC Announcement) the signing of a non-binding letter of interest to provide a subsidiary of the Company with a potential $765 million loan (the “DFC Loan”) to support the launch of Kodak Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs (the “DFC Pharmaceutical Project”). The DFC Loan would be for facility upgrades and construction, provide working capital, and finance other necessary direct expenditures supporting the launch of Kodak Pharmaceuticals. The signing of the letter of interest indicated Kodak’s successful completion of the DFC’s initial screening, which would be followed by standard due diligence conducted by the DFC before financing would be formally committed. The application process for the DFC Loan was put on hold when investigations were commenced with respect to the circumstances surrounding the DFC Announcement. While the letter of interest with the DFC has never been formally terminated and the Company has not received any communication from the DFC rejecting its application, given the time that has elapsed and the recent changes in administration at the federal government and the DFC, the Company is operating on the basis that the DFC Loan as envisioned at the time of the DFC Announcement will not proceed. The Company remains interested in working with the DFC and other governmental agencies to leverage its assets and technology to on-shore manufacturing of pharmaceutical and other healthcare materials. As described under “Overview” above, the Company is also continuing to explore expanding further into the pharmaceutical space on a smaller scale than contemplated by the DFC Loan using other sources of capital, including a portion of the capital raised by the Company on February 26, 2021.

Kodak made net contributions (funded plans) or paid benefits (unfunded plans) totaling approximately $8$6 million to its defined benefit pension and postretirement benefit plans in the first ~~nine~~six months of ~~2021.~~2022. For the balance of ~~2021,~~2022, the forecasted contribution (funded plans) and benefit payment (unfunded plans) requirements for its pension and postretirement plans are approximately $8 million.

Cash flow from investing activities included ~~$10~~$9 million of capital expenditures for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. Kodak expects approximately ~~$15~~$35 million to ~~$25~~$50 million of total capital expenditures for ~~2021, before consideration~~2022. The expected increase in capital expenditures in 2022 is driven by investments in growth initiatives and back‐office automation.

U.S. International Development Finance Corporation Non-Binding Letter of ~~any investment~~Interest

On July 28, 2020, the U.S. International Development Finance Corporation (“DFC”) signed a non-binding letter of interest to provide a subsidiary of the Company with a potential $765 million loan to support the launch of Kodak Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs. The letter of interest was entered into by the DFC pursuant to authority under the Defense Production Act granted to the DFC by Presidential Executive Order 13922. The Company has previously reported that, given the time that has elapsed and the changes in administration at the federal government and the DFC, the Company has been operating on the basis that the DFC Loan as envisioned at the time of the DFC Announcement would not proceed. On April 22, 2022, the Company received a letter from the DFC advising the Company that the authority conferred on the DFC by Executive Order 13922 expired on March 27, 2022 and that, consequently, the DFC is unable to consider the project further and the Company’s application has been closed.

Kodak, as a result of its global operating and financing activities, is exposed to changes in foreign currency exchange rates, commodity prices, and interest rates, which may adversely affect its results of operations and financial position. In seeking to minimize the risks associated with such activities, Kodak may ~~make utilizing proceeds~~enter into derivative contracts. Kodak does not utilize financial instruments for trading or other speculative purposes. Foreign currency forward contracts are used to hedge existing foreign currency denominated assets and liabilities, especially those of Kodak’s International Treasury Center, as well as forecasted foreign currency denominated intercompany sales.

Kodak’s exposure to changes in interest rates results from ~~the first quarter 2021 financing transactions.~~its investing and borrowing activities used to meet its liquidity needs. Long‐term debt is generally used to finance long‐term investments, while short‐term debt is used to meet working capital requirements.

Using a sensitivity analysis based on estimated fair value of open foreign currency forward contracts using available forward rates, if the U.S. dollar had been 10% stronger at June 30, 2022 and December 31, 2021, the fair value of open forward contracts would have decreased $10 million and $14 million, respectively. Such changes in fair value would be substantially offset by the revaluation or settlement of the underlying positions hedged.

The majority of the Company’s debt is fixed rate debt. The fair market value of fixed‐rate debt is sensitive to changes in interest rates. At both June 30, 2022 and December 31, 2021, a 10% change in market interest rates would change the fair value of the Company’s debt by approximately $1 million.

Kodak’s financial instrument counterparties are high‐quality investment or commercial banks with significant experience with such instruments. Kodak manages exposure to counterparty credit risk by requiring specific minimum credit standards and diversification of counterparties. Kodak has procedures to monitor the credit exposure amounts. The maximum credit exposure at June 30, 2022 was not significant to Kodak.

Kodak maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Kodak’s reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Kodak’s management, with the participation of Kodak’s Executive Chairman and Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of Kodak’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q and have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, Kodak’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.

There have been no changes in Kodak’s internal control over financial reporting during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, Kodak’s internal control over financial reporting.

~~On August 13, 2020 Tiandong Tang commenced a class action lawsuit against the Company, its Executive Chairman~~See Note 7, “Commitments and ~~Chief Executive Officer and its Chief Financial Officer in Federal District Court~~Contingencies” in the District of New Jersey, and on August 26, 2020 Jimmie A. McAdams and Judy P. McAdams commenced a class action lawsuit against the Company and its Executive Chairman and Chief Executive Officer in Federal District Court in the Southern District of New York (collectively, the “Securities Class Actions”). The Securities Class Actions seek damages and other relief based on alleged violations of federal securities laws in the context of the DFC Announcement of the potential DFC Loan and DFC Pharmaceutical Project. The Securities Class Actions were transferredNotes to the ~~Federal District Court~~Financial Statements included in Part I, Item 1, “Financial Statements and Supplementary Data” for the Western District of New York and were consolidated into a single proceeding (the “Consolidated Securities Class Action”) on June 22, 2021. Les Investissements Kiz Inc. and UAT Trading Service, Inc. were appointed by the court to serve as lead plaintiff for the Consolidated Securities Class Action on August 2, 2021, and the lead plaintiff filed an amended consolidated complaint on October 1, 2021. The Company intends to vigorously defend itself against the Consolidated Securities Class Action.

~~On December 29, 2020 Robert Garfield commenced a class action lawsuit against the Company and current and former members of its Board of Directors~~information regarding certain legal proceedings in the Superior Court of Mercer County, New Jersey seeking equitable relief and damages in favor of the Company based on alleged breaches of fiduciary duty by the Company’s Board of Directors associated with alleged false and misleading proxy statement disclosures (including the successor New York lawsuit discussed below, the “Fiduciary Class Action”). The Company and each of the individual defendants filed motions to dismiss the Fiduciary Class Action on April 13, 2021. The plaintiff in the Fiduciary Class Action voluntarily dismissed the Fiduciary Class Action without prejudice on May 26, 2021 and filed a lawsuit substantially similar to the dismissed New Jersey lawsuit in the Supreme Court of the State of New York in Monroe County on October 27, 2021, this time on behalf of a purported class of beneficial and record owners of stock of the Company as of March 26, 2020 who continue to own such stock through the present. The Company intends to vigorously defend itself against the Fiduciary Class Action.

The Company has also received five requests under New Jersey law demanding, among other things, that the Company take certain actions in response to alleged breaches of fiduciary duty relating to option grants and securities transactions in the context of the DFC Announcement and alleged proxy statement disclosure deficiencies (the “Derivative Demands”). On May 19, 2021 Louis Peters, one of the persons making a Derivative Demand (“Peters”), commenced a derivative lawsuit on behalf of the Company against certain officers and current and former directors of the Company and the Company as a nominal defendant in the Supreme Court of the State of New York in Monroe County seeking damages and equitable relief based on alleged breaches of fiduciary duty and unjust enrichment resulting from stock trades, option grants and a charitable contribution in the context of the DFC Announcement of the potential DFC Loan and DFC Pharmaceutical Project (the “State Derivative Lawsuit”). The plaintiff filed an amended complaint in the State Derivative Lawsuit on August 23, 2021, and the Company and individual defendants filed motions to dismiss (or alternatively, in the case of the Company, a motion for summary judgment) in the State Derivative Lawsuit on October 22, 2021. On September 2, 2021 Herbert Silverberg, another person making a Derivative Demand (“Silverberg”), commenced a derivative lawsuit on behalf of the Company against one current and one former director of the Company and the Company as a nominal defendant in the Federal District Court for the Western District of New York seeking damages and equitable relief on a basis overlapping with the State Derivative Lawsuit and alleged proxy statement misrepresentations and omissions. On October 4, 2021 Peters commenced a derivative lawsuit on behalf of the Company against the same parties named in the State Derivative Lawsuit in the Federal District Court for the Western District of New York seeking damages and equitable relief on a basis overlapping with the State Derivative Lawsuit and alleged violations of Section 10(b) of the Exchange Act. A process is underway to consolidate the Federal derivative lawsuits filed by Silverberg and Peters (the “Federal Derivative Lawsuits”) and appoint a lead plaintiff in the Federal Derivative Lawsuits. Additional shareholder derivative lawsuits may be brought based on the other Derivative Demands (any such lawsuits, collectively with the State Derivative Lawsuit, the Federal Derivative Lawsuits and the Fiduciary Class Action, the “Fiduciary Matters”). The Company, acting through a Special Committee of Independent Directors, previously determined that there was no merit to the claims alleged by the Derivative Demands (except with respect to the charitable contribution, which was not fully considered by the Special Committee). See the Company’s Current Report on Form 8-K filed with the SEC on September 16, 2020. The Company, acting through a separate Special Litigation Committee of Independent Directors, concurred with the first Special Committee’s findings and further concluded it is not in the Company’s interest to bring or allow any other shareholder to assert any of the claims alleged by the State Derivative Lawsuit or Federal Derivative Lawsuits (with the exception of the Peters claim purportedly arising under Section 10(b) of the Exchange Act, which was not addressed as no demand was made with respect to such claim). The second Special Litigation Committee will carefully review any other additional complaints constituting Fiduciary Matters which may be filed.

~~The DFC Announcement has also prompted investigations by several congressional committees and the SEC. The Company is cooperating with those investigations.~~

The Company has completed its document production and its officers have provided the testimony as contemplated by such order. The Company intends to vigorously defend itself against the Threatened Claim should it be filed.

Kodak’s Brazilian operations are involved in various litigation matters in Brazil and have received or been the subject of numerous governmental assessments related to indirect and other taxes in various stages of litigation, as well as civil litigation and disputes associated with former employees and contract labor. The tax matters, which comprise the majority of the litigation matters, are primarily related to federal and state value-added taxes and income taxes. Kodak’s Brazilian operations are disputing these matters and intend to vigorously defend their position. Kodak routinely assesses these matters as to the probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. As of September 30, 2021, Kodak’s Brazilian Operations maintained accruals of approximately $3 million for claims aggregating approximately $112 million inclusive of interest and penalties where appropriate. In connection with assessments and litigation in Brazil, local regulations may require Kodak’s Brazilian Operations to post security for a portion of the amounts in dispute. Generally, any encumbrances on the Brazilian assets would be removed to the extent the matter is resolved in Kodak’s favor.

~~In addition,~~ Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. Kodak is also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s products. These matters are in various stages of investigation and litigation and are being vigorously defended. Based on information currently available, Kodak does not believe that it is probable that the outcomes in any of these matters, individually or collectively, will have a material adverse effect on its financial condition or results of operations. Litigation is inherently unpredictable, and judgments could be rendered or settlements entered that could adversely affect Kodak’s operating results or cash flows in a particular period. Kodak routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.involved.

~~Reference is made to~~See the Risk Factors set forth in Part I, Item 1A. of the ~~2020~~2021 Form ~~10-K. The Risk Factors remain applicable from the 2020 Form 10-K.~~ 10-K for a detailed discussion of risk factors that could materially affect Kodak’s business, financial condition and results of operations.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Commission File Number
1-00087
EASTMAN KODAK COMPANY (Exact name of registrant as specified in its charter)
New Jersey		16-0417150
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

343 STATE STREET, ROCHESTER, New York		14650
(Address of principal executive offices)		(Zip Code)
(585) 724-4000
(Registrant’s telephone number, including area code)

Title of each class Common	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.01 per share	KODK	New York Stock Exchange

Large accelerated filer	☐	Accelerated filer	☐☒
Non-accelerated filer	☒☐	Smaller reporting company	☒☐
Emerging growth company	☐

		Page
Part I.—Financial Information

Item 1.	Financial Statements	2
	Consolidated Statement of Operations (Unaudited)	2
	Consolidated Statement of Comprehensive Income ~~(Loss)~~ (Unaudited)	3
	Consolidated Statement of Financial Position (Unaudited)	4
	Consolidated Statement of Cash Flows (Unaudited)	5
	Consolidated Statement of Equity (Deficit) (Unaudited)	6
	Notes to Financial Statements (Unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3529
	Liquidity and Capital Resources	4338
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	41
Item 4.	Controls and Procedures	4743

Part II. —Other Information

Item 1.	Legal Proceedings	4843
Item 1A.	Risk Factors	5044
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5044
Item 6.	Exhibits	51
		45
	Index to Exhibits	5145
	Signatures	5246

	Carrying Value		Maturity Value		Carrying Value		Maturity Value
Q4 2021	$	1	$	1
2022		2		2
Q3 - Q4 2022						1		1
2023		1		1		2		2
2024		1		1		1		1
2025		1		1		1		1
2026 and thereafter		246		317
2026						295		367
2027 and thereafter						9		9
Total	$	252	$	323	$	309	$	381

(in millions)
Deferred revenue on extended warranties as of December 31, 2020	$	19
Deferred revenue on extended warranties as of December 31, 2021				$	19
New extended warranty and maintenance arrangements deferred		67			45
Recognition of extended warranty and maintenance arrangement revenue		(68	)		(45	)
Deferred revenue on extended warranties as of September 30, 2021	$	18
Deferred revenue on extended warranties as of June 30, 2022				$	19

	Valuation Date
				February 26,			Valuation Date
	September 30,			2021			June 30,			December 31,
	2021			(Inception)			2022			2021
Total value of embedded derivative liability ($ millions)	$	7		$	12		$	4		$	4
Kodak's closing stock price	$	6.81		$	8.62		$	4.64		$	4.68
Expected stock price volatility		47.50	%		70.00	%		45.00	%		36.00	%
Risk free rate		0.90	%		0.80	%		3.00	%		1.17	%
Implied credit spread on the Convertible Notes		18.41	%		18.25	%		25.38	%		18.89	%

	Valuation Date
				March 30,			February 26,			Valuation Date
				2021			2021			June 30,			December 31,
	September 30, 2021			(Inception - Final Sale)			(Inception - Initial Sale)			2022			2021
Total value of embedded derivative liability ($ millions)	$	2		$	1		$	1		$	1		$	2
Kodak's closing stock price	$	6.81		$	8.05		$	8.62		$	4.64		$	4.68
Expected stock price volatility		47.50	%		70.00	%		70.00	%		45.00	%		36.00	%
Risk free rate		0.90	%		0.94	%		0.80	%		3.00	%		1.17	%
Implied credit spread on the preferred stock		21.91	%		21.75	%		21.75	%		28.38	%		21.39	%

	Three Months Ended September 30,															Nine Months Ended September 30,
(in millions)	2021			% of Sales			2020			% of Sales			$ Change			2021			% of Sales			2020			% of Sales			$ Change
Revenues	$	287					$	252					$	35		$	843					$	732					$	111
Cost of revenues		244						221						23			712						644						68
Gross profit		43			15	%		31			12	%		12			131			16	%		88			12	%		43
Selling, general and administrative expenses		43			15	%		56			22	%		(13	)		131			16	%		138			19	%		(7	)
Research and development costs		8			3	%		8			3	%		0			24			3	%		25			3	%		(1	)
Restructuring costs and other		—			0	%		1			0	%		(1	)		1			0	%		9			1	%		(8	)
Other operating expense (income), net		1			0	%		(1	)		(0	)%		2			(6	)		(1	)%		(11	)		(2	)%		5
Loss from operations before interest expense, pension income excluding service cost component, loss on early extinguishment of debt, other (income) charges, net and income taxes		(9	)		(3	)%		(33	)		(13	)%		24			(19	)		(2	)%		(73	)		(10	)%		54
Interest expense		9			3	%		3			1	%		6			23			3	%		11			2	%		12
Pension income excluding service cost component		(25	)		(9	)%		(26	)		(10	)%		1			(76	)		(9	)%		(79	)		(11	)%		3
Loss on early extinguishment of debt		-			0	%		2			1	%		(2	)		-			0	%		2			0	%		(2	)
Other (income) charges, net		(2	)		(1	)%		432			171	%		(434	)		(1	)		(0	)%		387			53	%		(388	)
Earnings (loss) from operations before income taxes		9			3	%		(444	)		(176	)%		453			35			4	%		(394	)		(54	)%		429
Provision for income taxes		1			0	%		1			0	%		0			5			1	%		167			23	%		(162	)
Net income (loss)	$	8			3	%	$	(445	)		(177	)%	$	453		$	30			4	%	$	(561	)		(77	)%	$	591

	Total Number of Shares Purchased ⁽¹⁾		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs ⁽²⁾	Maximum Number of Shares That May Yet Be Purchased under the Plans or Programs ⁽²⁾
July 1 through 31		—		—	n/a	n/a
August 1 through 31		—		—	n/a	n/a
September 1 through 30		19,034	$	7.22	n/a	n/a
Total		19,034	$	7.22

Exhibit Number

(3.1)		Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement on Form S-8 as filed on September 3, 2013).

(3.2)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company. (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed November 16, 2016).

(3.3)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit (3.1) of the Company’s Current Report on Form 8-K as filed September 12, 2019).

(3.4)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit (3.2) of the Company’s Current Report on Form 8-K as filed September 12, 2019).

(3.5)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed December 29, 2020).

(3.6)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed March 1, 2021).

(3.7)		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K as filed March 1, 2021).

(3.8)		Fourth Amended and Restated By-Laws of Eastman Kodak Company (Incorporated by reference to Exhibit (3.5) of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 as filed on May 12, 2020).

(31.1)		Certification signed by James V. Continenza, filed herewith.

(31.2)		Certification signed by David E. Bullwinkle, filed herewith.

(32.1)		Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by James V. Continenza, filed herewith.

(32.2)		Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 signed by David E. Bullwinkle, filed herewith.

(101.CAL)		Inline XBRL Taxonomy Extension Calculation Linkbase.

(101.INS)		Inline XBRL Instance Document.

(101.LAB)		Inline XBRL Taxonomy Extension Label Linkbase.

(101.PRE)		Inline XBRL Taxonomy Extension Presentation Linkbase.

(101.SCH)		Inline XBRL Taxonomy Extension Schema Linkbase.

(101.DEF)		Inline XBRL Taxonomy Extension Definition Linkbase

(104)		Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).

		EASTMAN KODAK COMPANY
		(Registrant)


Date: ~~November~~August 9, ~~2021~~2022		/s/ Richard T. Michaels
		Richard T. Michaels
		Chief Accounting Officer and Corporate Controller
		(Chief Accounting Officer and Authorized Signatory)